JPH07108906B2 - Phthalide derivative - Google Patents

Phthalide derivative

Info

Publication number
JPH07108906B2
JPH07108906B2 JP22826486A JP22826486A JPH07108906B2 JP H07108906 B2 JPH07108906 B2 JP H07108906B2 JP 22826486 A JP22826486 A JP 22826486A JP 22826486 A JP22826486 A JP 22826486A JP H07108906 B2 JPH07108906 B2 JP H07108906B2
Authority
JP
Japan
Prior art keywords
added
room temperature
group
formula
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP22826486A
Other languages
Japanese (ja)
Other versions
JPS6383081A (en
Inventor
義光 小川
政雄 陳
邦男 穂坂
潔 久保田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsumura and Co
Original Assignee
Tsumura and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsumura and Co filed Critical Tsumura and Co
Priority to JP22826486A priority Critical patent/JPH07108906B2/en
Publication of JPS6383081A publication Critical patent/JPS6383081A/en
Publication of JPH07108906B2 publication Critical patent/JPH07108906B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は、プロスタグランジンF2α阻害作用を有し、医
薬品として有用な新規なフタリド誘導体に関するもので
ある。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel phthalide derivative having a prostaglandin F2α inhibitory action and useful as a medicine.

セリ科の植物である生薬の川 (Cnidii Rhizoma)は、中枢抑制作用、筋弛緩作用、抗
血栓作用等が知られており、漢方薬である温経湯、温清
飲、葛根湯加川 辛夷等に配剤されている生薬である。
A river of crude drugs, which is a plant in the Aeriaceae family (Cnidii Rhizoma) is known to have central depressant action, muscle relaxant action, antithrombotic action, etc., and it is a Chinese medicine, Unkeito, Unseiin, Kakkonto Kagawa. It is a crude drug that is distributed in Chinese cabbage.

本発明者等は、この川 に含まれる成分の一つであるフタリドに着目し、鋭意研
究を重ねた結果、プロスタグランジンF2α阻害作用を有
するフタリド誘導体の合成に成功し、本発明を完成する
に至った。
The present inventors As a result of intensive studies, focusing on phthalide, which is one of the components contained in the above, the inventors have succeeded in synthesizing a phthalide derivative having a prostaglandin F2α inhibitory action and completed the present invention.

すなわち本発明は、一般式I (式中、R1は水素原子、水酸基、メトキシ基またはニト
ロ基を示し、R2は水素原子、水酸基、メトキシ基または
メトキシメトキシ基を示し、R3は水素原子またはメトキ
シ基を示し、R4は水素原子またはニトロ基を示し、R5
水素、アルキル基、−C3H6COOH、−C3H6COOC2H5または
−C4H8OHを示す。
That is, the present invention relates to the general formula I (In the formula, R 1 represents a hydrogen atom, a hydroxyl group, a methoxy group or a nitro group, R 2 represents a hydrogen atom, a hydroxyl group, a methoxy group or a methoxymethoxy group, R 3 represents a hydrogen atom or a methoxy group, and R 4 Represents a hydrogen atom or a nitro group, R 5 represents hydrogen, an alkyl group, —C 3 H 6 COOH, —C 3 H 6 COOC 2 H 5 or —C 4 H 8 OH.

ただし、R1、R2、R3およびR4が共通して水素原子である
場合、R1が水素原子であり、R2が水酸基であり、R3およ
びR4がともに水素原子であり、R5がn−プロピル基であ
る場合、およびR1およびR2がともに水素原子であり、R3
がメトキシ基であり、R4が水素原子であり、R5がメチル
基である場合、およびR1およびR2がメトキシ基であり、
R3およびR4が水素原子であり、R5がメチル基である場
合、およびR1が水酸基であり、R2、R3およびR4がともに
水素原子であり、R5がプロピル基である場合を除く。) で表される新規なフタリド誘導体である。
However, when R 1 , R 2 , R 3 and R 4 are hydrogen atoms in common, R 1 is a hydrogen atom, R 2 is a hydroxyl group, R 3 and R 4 are both hydrogen atoms, R 5 is an n-propyl group, and R 1 and R 2 are both hydrogen atoms, and R 3
Is a methoxy group, R 4 is a hydrogen atom, R 5 is a methyl group, and R 1 and R 2 are methoxy groups,
When R 3 and R 4 are hydrogen atoms, R 5 is a methyl group, and R 1 is a hydroxyl group, R 2 , R 3 and R 4 are both hydrogen atoms, and R 5 is a propyl group. Excluding cases. ) Is a novel phthalide derivative.

一般式Iで表される本発明のフタリド誘導体(以下、式
Iの化合物と称する)は、式II (式中、R1〜R4は上述と同様の意義を示す)で表される
化合物にリチウム化剤を、次いで酸を作用させ、さらに
式III R5−CHO III (R5は上述と同様の意義を示す) で表されるアルデヒド(以下、式IIIの化合物と称す
る)と反応させて式IV (式中、R1、R2、R3およびR4は上述と同様の意義を示
す) で表される化合物(以下、式IVの化合物と称する)を
得、これを有機溶媒中でメシル化して式V (式中、R1、R2、R3、R4およびR5は上述と同様の意義を
示し、Msはメシル基を示す) で表される化合物(以下、式Vの化合物と称する)とし
た後、アミン類等の塩基を作用させることにより得るこ
とができる。
The phthalide derivative of the present invention represented by the general formula I (hereinafter referred to as the compound of the formula I) has the formula II (In the formula, R 1 to R 4 have the same meanings as described above) A compound represented by formula (3) R 5 —CHO III (R 5 is the same as above) Of the formula IV) (hereinafter referred to as the compound of formula III) (Wherein R 1 , R 2 , R 3 and R 4 have the same meanings as described above) (hereinafter referred to as the compound of formula IV), and mesylate this in an organic solvent. Formula V (Wherein R 1 , R 2 , R 3 , R 4 and R 5 have the same meanings as described above and Ms represents a mesyl group) (hereinafter referred to as a compound of formula V) After that, it can be obtained by reacting a base such as amines.

出発原料である式IIの化合物は、目的物質に応じて市販
のm−アニス酸、3,4−ジメトキシ安息香酸、3,4,5−ト
リメトキシ安息香酸等を塩化アシルとした後、2−アミ
ノ−2−メチル−1−プロパノールと反応させ更に環化
させることにより式A (R1、R2、R3およびR4は上述と同様の意義を示す) で表される化合物(以下、式Aの化合物と称する)とし
た後、次いでホルムアルデヒドを作用させ、更に酸を作
用させることにより得ることができる。
The compound of formula II, which is a starting material, is prepared by converting commercially available m-anisic acid, 3,4-dimethoxybenzoic acid, 3,4,5-trimethoxybenzoic acid or the like into acyl chloride and then using 2-amino By reacting with 2-methyl-1-propanol for further cyclization (Wherein R 1 , R 2 , R 3 and R 4 have the same meanings as described above) (hereinafter referred to as the compound of formula A), formaldehyde is then allowed to act, and then an acid is allowed to act. Can be obtained.

塩化アシルを得るには、m−アニス酸、3,4−ジメトキ
シ安息香酸、3,4,5−トリメトキシ安息香酸等に、塩化
チオニル、5塩化リン、3塩化リン、オキザリルクロリ
ド等を氷冷下で加え反応させる。反応温度は、室温から
60℃程度が適当である。反応後は常圧または減圧しての
溶媒留去、蒸留等の通常用いられる一般的な精製手法に
より塩化アシルを得ることができる。
Acyl chloride can be obtained by adding thionyl chloride, phosphorus pentachloride, phosphorus trichloride, oxalyl chloride, etc. to m-anisic acid, 3,4-dimethoxybenzoic acid, 3,4,5-trimethoxybenzoic acid, etc. with ice-cooling. Add below to react. The reaction temperature is from room temperature
About 60 ℃ is suitable. After the reaction, the acyl chloride can be obtained by a commonly used general purification method such as distillation of the solvent at atmospheric pressure or reduced pressure, distillation.

次いで、この塩化アシルを有機溶媒中、2−アミノ−2
−メチル−1−プロパノールを加えて反応させ、アミド
体とする。有機溶媒の具体例としては、塩化メチレン、
ベンゼン、クロロホルム等が挙げられ、反応温度として
は、0〜30℃程度が適当である。常法で十分反応し得る
が、アルゴン置換を行うことなどにより、無水条件下で
反応させることが好ましい。反応後は抽出、乾燥、溶媒
留去等の通常用いられる一般的な精製手法により、アミ
ド体を得る。
Then, this acyl chloride is treated with 2-amino-2 in an organic solvent.
-Methyl-1-propanol is added and reacted to form an amide form. Specific examples of the organic solvent include methylene chloride,
Examples of the reaction temperature include benzene and chloroform, and a suitable reaction temperature is 0 to 30 ° C. Although the reaction can be sufficiently carried out by a conventional method, it is preferable to carry out the reaction under anhydrous conditions, such as by performing argon substitution. After the reaction, the amide compound is obtained by a commonly used general purification technique such as extraction, drying and solvent removal.

さらに、このアミド体に塩化チオニルを反応させること
により環化させて式Aの化合物を得る。反応温度は、室
温程度が適当である。反応後は抽出、乾燥、溶媒留去等
の通常用いられる一般的な精製手法により式Aの化合物
を得ることができる。
Further, this amide compound is cyclized by reacting with thionyl chloride to obtain a compound of the formula A. A suitable reaction temperature is about room temperature. After the reaction, the compound of the formula A can be obtained by a commonly used general purification technique such as extraction, drying and solvent removal.

次に、上述のようにして得られた式Aの化合物に有機溶
媒中、塩基の存在下、ホルムアルデヒドを反応させ、続
いて酸を加えて加水分解し、式IIの化合物とする。使用
する有機溶媒としては、無水テトラヒドロフラン、ジエ
チルエーテル、1,2−ジメトキシエタン、ジエチレング
リコールジメチルエーテル等のエーテル類が挙げられ、
塩基の具体例としては、n−ブチルリチウム、sec−ブ
チルリチウム、tert−ブチルリチウム等が挙げられる。
反応温度としては−45℃から室温程度が適当であるが、
特に低温の場合には、キレート剤としてテトラメチルエ
チレンジアミンを加えることが好ましい。続いて酸を加
えて加水分解を行うが、好ましくは前の反応に用いたホ
ルムアルデヒド等を除去してから加水分解するのが良
い。酸の具体例としては、塩酸、硫酸等の鉱酸が挙げら
れ、使用する溶媒としては、水またはアルコール類また
はその混合溶媒が適当である。反応温度は、室温から使
用する溶媒の沸点まで加熱して反応させるのが好まし
い。反応後は抽出、乾燥、溶媒留去および再結晶等の通
常用いられる一般的な精製手法を組み合わせることによ
り式IIの化合物を得ることができる。
Next, the compound of formula A obtained as described above is reacted with formaldehyde in the presence of a base in an organic solvent, and then an acid is added to hydrolyze the compound to give a compound of formula II. Examples of the organic solvent used include ethers such as anhydrous tetrahydrofuran, diethyl ether, 1,2-dimethoxyethane, and diethylene glycol dimethyl ether.
Specific examples of the base include n-butyllithium, sec-butyllithium, tert-butyllithium and the like.
As the reaction temperature, about −45 ° C. to room temperature is suitable,
Particularly at low temperatures, it is preferable to add tetramethylethylenediamine as a chelating agent. Subsequently, an acid is added to carry out the hydrolysis, but it is preferable to remove the formaldehyde and the like used in the previous reaction and then carry out the hydrolysis. Specific examples of the acid include mineral acids such as hydrochloric acid and sulfuric acid, and the solvent to be used is preferably water, alcohols or a mixed solvent thereof. The reaction temperature is preferably room temperature to the boiling point of the solvent used for the reaction. After the reaction, the compound of the formula II can be obtained by combining commonly used general purification techniques such as extraction, drying, evaporation of the solvent and recrystallization.

また、式IIの化合物を得る別の方法としては、3,4,5−
トリメトキシ安息香酸、3,5−ジメトキシ−4−ヒドロ
キシ安息香酸等の安息香酸類に酸の存在下、ジメトキシ
メタンまたはパラホルムアルデヒドを反応させる方法お
よび、更に必要に応じて水酸基をメトキシメチル化する
方法も挙げることができる。ここで用いる酸としては、
塩酸、硫酸等の鉱酸が挙げられ、反応温度としては室温
から70℃程度に加熱するのが好ましい。ここでの反応
は、安息香酸類のカルボキシル基のオルト位における置
換反応であるため、その他の位置にはどのような置換基
が存在しても反応は同様に進行する。また、副生成物の
生成を防ぐためには、カルボキシル基のオルト位が1つ
だけ置換されているものか、カルボキシル基の2つのメ
タ位に同じ置換基が存在するものを用いることが好まし
い。
Another method for obtaining the compound of formula II is 3,4,5-
Trimethoxybenzoic acid, benzoic acid such as 3,5-dimethoxy-4-hydroxybenzoic acid in the presence of an acid, in the presence of an acid, a method of reacting dimethoxymethane or paraformaldehyde, and also a method of methoxymethylating a hydroxyl group, if necessary. be able to. The acid used here is
Mineral acids such as hydrochloric acid and sulfuric acid may be mentioned, and the reaction temperature is preferably from room temperature to about 70 ° C. Since the reaction here is a substitution reaction at the ortho position of the carboxyl group of benzoic acids, the reaction proceeds similarly regardless of the presence of any substituents at other positions. Further, in order to prevent the formation of by-products, it is preferable to use one in which one ortho position of the carboxyl group is substituted, or one in which the same substituent is present in two meta positions of the carboxyl group.

さらに必要に応じて、無水テトラヒドロフラン、アセト
ン、ジメチルホルムアミド等の有機溶媒中、N,N−ジイ
ソプロピルエチルアミン、水酸化ナトリウム、水酸化カ
リウム、炭酸ナトリウム、炭酸カリウム、トリエチルア
ミン等の塩基を加え、クロロメチルメチルエーテル等を
反応させることにより、水酸基をメトキシメチル化する
ことができる。
Further, if necessary, in an organic solvent such as anhydrous tetrahydrofuran, acetone, dimethylformamide, a base such as N, N-diisopropylethylamine, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, triethylamine is added, and chloromethylmethyl is added. The hydroxyl group can be methoxymethylated by reacting with ether or the like.

上記反応において、溶媒として用いるジメチルホルムア
ミドは、強塩基の存在により加水分解するため、ジメチ
ルホルムアミドを使用する場合には、塩基としてN,N−
ジイソプロピルエチルアミンまたはトリエチルアミン等
のアミン類を用いるのが好ましい。
In the above reaction, dimethylformamide used as a solvent is hydrolyzed in the presence of a strong base, and therefore, when dimethylformamide is used, N, N-
It is preferable to use amines such as diisopropylethylamine or triethylamine.

以下に、式IIの化合物の製造の具体例を示す。The following are specific examples of the production of the compound of formula II.

具体例1 3,4−ジメトキシ安息香酸30.0gに氷冷下で塩化チオニル
58.8gを加え、室温で終夜撹拌した。この反応混合物か
ら過剰の塩化チオニルを常圧で留去した後、減圧蒸留
し、緑白色粉状晶の3,4−ジメトキシ安息香酸クロリド3
0.2gを得た(収率91%)。
Example 1 Thionyl chloride was added to 30.0 g of 3,4-dimethoxybenzoic acid under ice cooling.
58.8 g was added, and the mixture was stirred at room temperature overnight. After distilling off excess thionyl chloride from this reaction mixture at atmospheric pressure, it was distilled under reduced pressure to obtain 3,4-dimethoxybenzoic acid chloride 3 as a green-white powdery crystal.
0.2 g was obtained (yield 91%).

2−アミノ−2−メチル−1−プロパノール22.3gをア
ルゴン置換した後、無水塩化メチレン50mlを加えて溶解
させ、この溶液に撹拌氷冷下、3,4−ジメトキシ安息香
酸クロリド25.1gの無水塩化メチレン溶液150mlを滴下
し、さらに室温で2時間撹拌した。この反応混合物に水
50mlを加えた後、クロロホルムで抽出(350ml×2)、
クロロホルム層を5%水酸化ナトリウム水溶液50ml、5
%塩酸50mlおよび飽和食塩水で洗浄、硫酸マグネシウム
で乾燥、溶媒を減圧留去し、無色アワ状物質を得た。こ
のN-(1,1−ジメチル−2−ヒドロキシエチル)‐3,4−
ジメトキシベンズアミドに塩化チオニルを加え、室温で
2時間撹拌した。この反応混合物にエーテル200mlを加
え、結晶化させて2-(3,4−ジメトキシフエニル)‐4,4
−ジメチルオキサゾリンの塩酸塩を白色結晶として濾取
した。この白色結晶を水100mlに溶解させた後、20%水
酸化ナトリウム水溶液でアルカリ性とし、エーテルで抽
出(250ml×2)、炭酸カリウムおよび硫酸マグネシウ
ムで乾燥、溶媒を減圧留去し黄色油状物質を得た。これ
を蒸留して、無色粘稠性物質の2-(3,4−ジメトキシフ
エニル)‐4,4−ジメチル−2−オキサゾリン24.4gを得
た(収率83%)。
After replacing 22.3 g of 2-amino-2-methyl-1-propanol with argon, 50 ml of anhydrous methylene chloride was added and dissolved, and this solution was stirred under ice-cooling with stirring and stirring for cooling with 25.1 g of 3,4-dimethoxybenzoic acid chloride (25.1 g). 150 ml of methylene solution was added dropwise, and the mixture was further stirred at room temperature for 2 hours. Water is added to this reaction mixture.
After adding 50 ml, extract with chloroform (350 ml x 2),
Chloroform layer is 5% sodium hydroxide aqueous solution 50 ml, 5
The extract was washed with 50% hydrochloric acid (50 ml) and saturated brine, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to give a colorless foam substance. This N- (1,1-dimethyl-2-hydroxyethyl) -3,4-
Thionyl chloride was added to dimethoxybenzamide, and the mixture was stirred at room temperature for 2 hours. To this reaction mixture was added 200 ml of ether and crystallized to give 2- (3,4-dimethoxyphenyl) -4,4
-The hydrochloride of dimethyloxazoline was filtered off as white crystals. The white crystals were dissolved in 100 ml of water, made alkaline with 20% aqueous sodium hydroxide solution, extracted with ether (250 ml × 2), dried over potassium carbonate and magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain a yellow oily substance. It was This was distilled to obtain 24.4 g of colorless viscous substance 2- (3,4-dimethoxyphenyl) -4,4-dimethyl-2-oxazoline (yield 83%).

2960,2925,2895,2836, 1646,1604,1586,1514, 1464,1422,1358,1310, 1272,1260,1232,1172, 1140,1078,1026,974, 764,714 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.38(6H,s),3.91(3H,s), 3.93(3H,s),4.08(2H,s), 6.86(1H,d,J=8.3Hz), 7.46(1H,d,J=2.0Hz), 7.53(1H,dd,J=8.3,2.0Hz) マススペクトル: M/Z(%) 235(M+,35), 220(100),205(7), 192(25),164(24), 148(5) この2-(3,4−ジメトキシフエニル)‐4,4−ジメチル−
2−オキサゾリン29.98gをアルゴン置換し、無水テトラ
ヒドロフラン270mlを加えて溶解させた後、−45℃に冷
却し撹拌下1.6Mn−ブチルリチウム95.6mlを加え、−45
℃で2時間撹拌した。この反応液に−45℃でパラホルム
アルデヒド11.48gを加え、−45℃で1時間撹拌した後、
室温で終夜撹拌した。この反応混合物に水を加え、エー
テルで抽出(300ml×2)、飽和食塩水で洗浄、硫酸マ
グネシウムで乾燥、溶媒を減圧除去して黄色油状物質を
得た。これに3N塩酸水溶液1.2lを加え、3時間加熱還流
した。この反応混合物を室温で終夜放置し、析出した針
状晶を濾取して、4,5−ジメトキシフタリド19.14gを得
た(収率77%)。
2960,2925,2895,2836, 1646,1604,1586,1514, 1464,1422,1358,1310, 1272,1260,1232,1172, 1140,1078,1026,974, 764,714 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 1.38 (6H, s), 3.91 (3H, s), 3.93 (3H, s), 4.08 (2H, s), 6.86 (1H, d, J = 8.3Hz), 7.46 (1H, d, J) = 2.0Hz), 7.53 (1H, dd, J = 8.3,2.0Hz) Mass spectrum: M / Z (%) 235 (M + , 35), 220 (100), 205 (7), 192 (25), 164 (24), 148 (5) This 2- (3,4-dimethoxyphenyl) -4,4-dimethyl-
After replacing 29.98 g of 2-oxazoline with argon and adding 270 ml of anhydrous tetrahydrofuran to dissolve it, the mixture was cooled to −45 ° C. and 95.6 ml of 1.6 Mn-butyllithium was added with stirring to give −45
The mixture was stirred at 0 ° C for 2 hours. 11.48 g of paraformaldehyde was added to this reaction solution at -45 ° C, and the mixture was stirred at -45 ° C for 1 hour.
Stir overnight at room temperature. Water was added to this reaction mixture, which was extracted with ether (300 ml × 2), washed with saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a yellow oily substance. To this was added 1.2 L of 3N hydrochloric acid aqueous solution, and the mixture was heated under reflux for 3 hours. The reaction mixture was left at room temperature overnight, and the precipitated needle crystals were collected by filtration to obtain 19.14 g of 4,5-dimethoxyphthalide (yield 77%).

2992,2964,2944,2836, 1752,1616,1498,1462, 1432,1368,1322,1276, 1226,1086,1024,996, 944,894,832,774,742, 656,562 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 3.95(3H,s),3.96(3H,s), 5.32(2H,s), 7.08(1H,d,J=8.3Hz), 7.62(1H,d,J=8.3Hz) マススペクトル: M/Z(%) 194(M+,94), 179(5),165(100), 151(18),137(11), 123(11),108(5), 92(5),77(13), 63(7) 具体例2 シリング酸(3,5−ジメトキシ−4−ヒドロキシ−安息
香酸)28.88gに35%塩酸570mlおよびジメトキシメタン1
4.2mlを加え、1.5時間加熱撹拌した。この反応液を室温
にもどして、クロロホルムで抽出(500ml×2)、飽和
炭酸水素ナトリウム水溶液および飽和食塩水で洗浄、硫
酸マグネシウムで乾燥、溶媒を減圧除去して、4,6−ジ
メトキシ−5−ヒドロキシフタリド16.97gを得た。
2992,2964,2944,2836, 1752,1616,1498,1462, 1432,1368,1322,1276, 1226,1086,1024,996, 944,894,832,774,742, 656,562 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 3.95 (3H , s), 3.96 (3H, s), 5.32 (2H, s), 7.08 (1H, d, J = 8.3Hz), 7.62 (1H, d, J = 8.3Hz) Mass spectrum: M / Z (%) 194 (M + , 94), 179 (5), 165 (100), 151 (18), 137 (11), 123 (11), 108 (5), 92 (5), 77 (13), 63 ( 7) Concrete Example 2 28.88 g of silicic acid (3,5-dimethoxy-4-hydroxy-benzoic acid) was added to 570 ml of 35% hydrochloric acid and 1 part of dimethoxymethane.
4.2 ml was added, and the mixture was heated and stirred for 1.5 hours. The reaction solution was returned to room temperature, extracted with chloroform (500 ml × 2), washed with saturated aqueous sodium hydrogen carbonate solution and saturated saline solution, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give 4,6-dimethoxy-5-. 16.97 g of hydroxyphthalide was obtained.

さらにこれを無水アセトン290mlに溶解させた後、炭酸
カリウム80.56gおよびメチルクロロメチルエーテル22.1
mlを加え、室温で終夜撹拌した。この反応混合物を減圧
除去してアセトンを除いた後、水を加え過剰の炭酸カリ
ウムを溶解させて不溶物を濾取した。これをベンゼンか
ら再結晶して、白色微針状晶の4,6−ジメトキシ−5−
メトキシメトキシ−フタリド12.10gを得た(収率33
%)。
Furthermore, after dissolving this in 290 ml of anhydrous acetone, 80.56 g of potassium carbonate and 22.1 of methyl chloromethyl ether were added.
ml was added, and the mixture was stirred at room temperature overnight. The reaction mixture was removed under reduced pressure to remove acetone, water was added to dissolve excess potassium carbonate, and the insoluble material was collected by filtration. This was recrystallized from benzene to give 4,6-dimethoxy-5-white fine needle crystals.
12.10 g of methoxymethoxy-phthalide was obtained (yield 33
%).

2952,2840,1758,1616, 1482,1446,1432,1408, 1374,1344,1254,1210, 1138,1120,1100,1042, 1012,928,856,760 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 3.61(3H,s),9.62(3H,s), 3.98(3H,s),5.20(2H,s), 5.32(2H,s),7.16(1H,s) マススペクトル: M/Z(%) 254(3,M+),224(2), 209(1),195(1), 181(2),178(1), 147(1),93(1), 45(100) 次に、上述のようにして得られた式IIの化合物に、有機
溶媒中リチウム化剤、次いで酸を作用させ、さらに式II
Iのアルデヒドと反応させる。リチウム化剤としては、
リチウムジイソプロピルアミド等が挙げられ、ルイス酸
としてはハロゲン化亜鉛、ハロゲン化マグネシウム等が
好ましく、具体的には塩化亜鉛、臭化亜鉛、ヨウ化亜
鉛、塩化マグネシウム、臭化マグネシウム、ヨウ化マグ
ネシウム等が挙げられる。用いる有機溶媒としては無水
テトラヒドロフラン、ジエチルエーテル等のエーテル類
が好ましく、式IIIのアルデヒドにおけるR5のアルキル
基の具体例としては、低級または中級アルキル基、好ま
しくは炭素数が1〜10程度のアルキル基であり、具体的
には、メチル基、エチル基、プロピル基、イソプロピル
基、n−ブチル基、イソブチル基、tert−ブチル基、se
c−ブチル基、n−ペンチル基、イソペンチル基、n−
ヘキシル基、n−ヘプチル基、n−オクチル基、n−ノ
ニル基、n−デシル基が挙げられ、−70℃から室温程度
で反応させるのが適当である。
2952,2840,1758,1616, 1482,1446,1432,1408, 1374,1344,1254,1210, 1138,1120,1100,1042, 1012,928,856,760 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 3.61 (3H , s), 9.62 (3H, s), 3.98 (3H, s), 5.20 (2H, s), 5.32 (2H, s), 7.16 (1H, s) Mass spectrum: M / Z (%) 254 (3 , M + ), 224 (2), 209 (1), 195 (1), 181 (2), 178 (1), 147 (1), 93 (1), 45 (100) Then, as described above The compound of formula II thus obtained is treated with a lithiating agent in an organic solvent and then with an acid to give a compound of formula II
React with I aldehyde. As a lithiating agent,
Lithium diisopropylamide and the like, and Lewis acid is preferably zinc halide, magnesium halide and the like, and specifically, zinc chloride, zinc bromide, zinc iodide, magnesium chloride, magnesium bromide, magnesium iodide and the like. Can be mentioned. The organic solvent used is preferably anhydrous tetrahydrofuran, ethers such as diethyl ether, and specific examples of the alkyl group of R 5 in the aldehyde of formula III include a lower or middle alkyl group, preferably an alkyl group having about 1 to 10 carbon atoms. Groups, specifically, methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, isobutyl group, tert-butyl group, se
c-butyl group, n-pentyl group, isopentyl group, n-
Examples thereof include a hexyl group, an n-heptyl group, an n-octyl group, an n-nonyl group and an n-decyl group, and it is suitable to react at -70 ° C to room temperature.

反応終了後は、抽出、乾燥、溶媒除去等の通常用いられ
る一般的な精製手法により式IVの化合物を得ることがで
きる。
After completion of the reaction, the compound of the formula IV can be obtained by a commonly used general purification technique such as extraction, drying and solvent removal.

次いで、有機溶媒中で式IVの化合物の2級の水酸基をメ
シル化して式Vの化合物を得る。メシル化の試薬として
は、メタンスルホニルクロリド−ピリジン等が挙げら
れ、有機溶媒の具体例としては、無水テトラヒドロフラ
ン、クロロホルム、塩化メチレン等が挙げられる。反応
は、室温から使用する溶媒の沸点程度まで加熱して行う
のが好ましい。
The secondary hydroxyl group of the compound of formula IV is then mesylated in an organic solvent to give the compound of formula V. Examples of the mesylation reagent include methanesulfonyl chloride-pyridine and the like, and specific examples of the organic solvent include anhydrous tetrahydrofuran, chloroform, methylene chloride and the like. The reaction is preferably carried out by heating from room temperature to about the boiling point of the solvent used.

さらに、式Vの化合物にアミン類を作用させることによ
り、メシル基を脱離させ、式Iの化合物とする。アミン
類の具体例としては、1,8−ジアザビシクロ[5,4,0]ウ
ンデカ−7−エン(DBU)、1,5−ジアザビシクロ[4,3,
0]ノナ−5−エン(DBN)等が挙げられ、用いる溶媒と
しては、ベンゼン等の有機溶媒が挙げられ、室温から使
用する溶媒の沸点程度まで加熱して行うのが好ましい。
反応終了後は、抽出、乾燥、溶媒除去等の通常用いられ
る一般的な精製手法により式Iの化合物を得ることがで
きる。
Further, the mesyl group is eliminated by reacting the compound of formula V with an amine to give a compound of formula I. Specific examples of amines include 1,8-diazabicyclo [5,4,0] undec-7-ene (DBU) and 1,5-diazabicyclo [4,3,
[0] Nona-5-ene (DBN) and the like can be mentioned. As the solvent to be used, an organic solvent such as benzene can be mentioned, which is preferably carried out by heating from room temperature to about the boiling point of the solvent to be used.
After completion of the reaction, the compound of the formula I can be obtained by a commonly used general purification technique such as extraction, drying and solvent removal.

上記のようにして得られた式Iの化合物に、さらに必要
に応じ、適宜脱メチル化、脱メトキシメチル化、還元等
の操作を施してもかまわない。
The compound of formula I obtained as described above may be optionally subjected to operations such as demethylation, demethoxymethylation and reduction, if necessary.

脱メチル化する場合には、水または有機溶媒中、酸を反
応させることにより達成できる。酸の具体例としては、
三臭化ホウ素、三塩化ホウ素、三フツ化ホウ素、三臭化
アルミニウム、三塩化アルミニウム、三フツ化アルミニ
ウム等のルイス酸、ヨウ化水素酸、臭化水素酸または塩
酸およびトリフルオロ酢酸等が挙げられる。使用する有
機溶媒の具体例としては、無水塩化メチレン、クロロホ
ルム、エタノール等が挙げられる。反応温度としては0
℃から室温程度が適当である。
Demethylation can be achieved by reacting an acid in water or an organic solvent. Specific examples of the acid include:
Examples include Lewis acids such as boron tribromide, boron trichloride, boron trifluoride, aluminum tribromide, aluminum trichloride, aluminum trifluoride, hydroiodic acid, hydrobromic acid or hydrochloric acid and trifluoroacetic acid. To be Specific examples of the organic solvent used include anhydrous methylene chloride, chloroform, ethanol and the like. 0 as reaction temperature
A temperature of about ℃ to room temperature is suitable.

脱メトキシメチル化する場合には、酸を加えて加熱する
ことにより達成できる。酸の具体例としては塩酸、硫
酸、リン酸等の鉱酸、または臭化亜鉛、チタニウムクロ
リド等のルイス酸が挙げられ、溶媒としてはメタノー
ル、エタノール等のアルコール類またはジオキサン等の
エーテル類が好適である。
Demethoxymethylation can be achieved by adding an acid and heating. Specific examples of the acid include mineral acids such as hydrochloric acid, sulfuric acid and phosphoric acid, and Lewis acids such as zinc bromide and titanium chloride, and the solvent is preferably alcohols such as methanol and ethanol or ethers such as dioxane. Is.

還元は、有機溶媒中ジボランを反応させて行う。有機溶
媒の具体例としては、無水テトラヒドロフラン、ジエチ
ルエーテル、1,2−ジメトキシエタン、ジエチレングリ
コールジメチルエーテル等のエーテル類が挙げられる。
還元剤としては、ジボラン等が挙げられるが、その他、
式Iの化合物のカルボキシル基のみを還元し得る還元試
薬であればいかなる試薬を用いてもかまわない。
The reduction is performed by reacting diborane in an organic solvent. Specific examples of the organic solvent include ethers such as anhydrous tetrahydrofuran, diethyl ether, 1,2-dimethoxyethane, and diethylene glycol dimethyl ether.
Examples of the reducing agent include diborane, and the like.
Any reagent may be used as long as it can reduce only the carboxyl group of the compound of formula I.

また、式Iの化合物を得る他の方法としては、下記式VI (式中、R1〜R4は上述と同様の意義を示す。)で表され
る化合物(以下、式VIの化合物と称する)に塩基の存在
下、式IIIのアルデヒドを作用させて式VII (式中、R1〜R5は上述と同様の意義を示す。)で表され
る化合物(以下、式VIIの化合物と称する)とし、次い
で酸化することにより式VIII (式中、R1〜R5は上述と同様の意義を示す。)で表され
る化合物(以下、式VIIIの化合物と称する)を得、これ
を環化脱水させる方法も挙げることができる。
Another method for obtaining the compound of formula I is the following formula VI (Wherein R 1 to R 4 have the same meanings as described above) (hereinafter referred to as a compound of formula VI) in the presence of a base, by reacting an aldehyde of formula III (Wherein R 1 to R 5 have the same meanings as described above) (hereinafter referred to as a compound of formula VII), and then oxidized to form a compound of formula VIII (In the formula, R 1 to R 5 have the same meanings as described above.) A compound (hereinafter, referred to as a compound of formula VIII) is obtained, and a method of cyclizing and dehydrating the compound can also be mentioned.

原料である式VIの化合物としては、市販の3−メトキシ
ベンジルアルコール、3,4−ジメトキシベンジルアルコ
ール、3,5−ジメトキシベンジルアルコール、3,4,5−ト
リメトキシベンジルアルコール等が挙げられる。使用す
る有機溶媒としては、無水テトラヒドロフラン、ジエチ
ルエーテル、1,2−ジメトキシエタン、ジエチレングリ
コールジメチルエーテル等のエーテル類が挙げられ、塩
基の具体例としては、n−ブチルリチウム、sec−ブチ
ルリチウム、tert−ブチルリチウム等が挙げられ、式II
Iのアルデヒドとしては上述したと同様のアルデヒドが
挙げられる。反応温度としては−80℃から還流温度程度
が適当であるが、特に低温の場合には、キレート剤とし
てテトラメチルエチレンジアミンを加えることが好まし
い。反応後は、通常用いられる一般的な精製手法により
式VIIの化合物を得ることができる。
Examples of the compound of formula VI as a raw material include commercially available 3-methoxybenzyl alcohol, 3,4-dimethoxybenzyl alcohol, 3,5-dimethoxybenzyl alcohol, and 3,4,5-trimethoxybenzyl alcohol. Examples of the organic solvent used include ethers such as anhydrous tetrahydrofuran, diethyl ether, 1,2-dimethoxyethane, and diethylene glycol dimethyl ether. Specific examples of the base include n-butyllithium, sec-butyllithium, and tert-butyl. Lithium and the like, formula II
Examples of the aldehyde of I include the same aldehydes as described above. A suitable reaction temperature is from -80 ° C to a reflux temperature, but it is preferable to add tetramethylethylenediamine as a chelating agent especially at low temperatures. After the reaction, the compound of formula VII can be obtained by a commonly used general purification technique.

上記の反応は、ベンジルアルコール類の2位の置換反応
であるため、他の位置にどのような置換基が存在しても
反応は同様に進行する。
Since the above reaction is a substitution reaction at the 2-position of benzyl alcohols, the reaction proceeds similarly even if any substituent is present at other positions.

次いで、式VIIの化合物を有機溶媒中で酸化する。用い
る酸化剤としては、過マンガン酸テトラブチルアンモニ
ウム等が挙げられ、有機溶媒の具体例としては、ピリジ
ン、ベンゼン等が挙げられ、反応は室温程度で行うのが
好ましい。反応終了後は、抽出、乾燥、溶媒除去等の通
常用いられる一般的な精製手法により式VIIIの化合物を
得ることができる。
The compound of formula VII is then oxidized in an organic solvent. Examples of the oxidizing agent used include tetrabutylammonium permanganate and the like, and specific examples of the organic solvent include pyridine, benzene and the like, and the reaction is preferably carried out at about room temperature. After completion of the reaction, the compound of the formula VIII can be obtained by a commonly used general purification technique such as extraction, drying and solvent removal.

さらに、これを有機溶媒中で環化脱水することにより式
Iの化合物を得る。用いる脱水剤としては、チオニルク
ロリド、硫酸等が挙げられ、有機溶媒の具体例としては
ベンゼン、クロロホルム、塩化メチレン等が挙げられ
る。反応温度は、室温から80℃前後まで加熱するのが好
ましく、反応終了後は、抽出、乾燥、溶媒除去等の通常
用いられる一般的な精製手法により式Iの化合物を得る
ことができる。
Further, this is subjected to cyclization dehydration in an organic solvent to obtain a compound of formula I. Examples of the dehydrating agent used include thionyl chloride and sulfuric acid, and specific examples of the organic solvent include benzene, chloroform, methylene chloride and the like. The reaction temperature is preferably heated from room temperature to around 80 ° C., and after completion of the reaction, the compound of the formula I can be obtained by a commonly used general purification technique such as extraction, drying and solvent removal.

上記のようにして得られた式Iの化合物に、さらに必要
に応じ、適宜脱メチル化、脱メトキシメチル化、還元等
の操作を施してもかまわない。脱メチル化、脱メトキシ
メチル化、還元等は、上述したと同様の条件下で達成さ
れる。
The compound of formula I obtained as described above may be optionally subjected to operations such as demethylation, demethoxymethylation and reduction, if necessary. Demethylation, demethoxymethylation, reduction and the like are achieved under the same conditions as described above.

更にまた、式Iの化合物を得る他の方法としては、あら
かじめ水酸基、メトキシ基、ニトロ基等で置換した無水
フタル酸類と、式B (R5CO)2O B (R5は、上述と同様の意義を示す。) で表される化合物(以下、式Bの化合物と称する)を酢
酸ナトリウムの存在下で反応させる方法も挙げることが
できる。
Furthermore, as another method for obtaining the compound of the formula I, phthalic anhydrides previously substituted with a hydroxyl group, a methoxy group, a nitro group or the like and a compound of the formula B (R 5 CO) 2 O B (R 5 are the same as those described above. The compound represented by the formula (hereinafter referred to as the compound of formula B) (hereinafter referred to as the compound of the formula B) can be reacted in the presence of sodium acetate.

無水フタル酸類の具体例としては、無水3−ニトロフタ
ル酸、無水4−ニトロフタル酸等が挙げられ、式Bの化
合物の具体例としては、無水酢酸、無水プロピオン酸、
無水酪酸、無水吉草酸、無水カプロン酸等が挙げられ
る。反応温度としては、室温から使用する溶媒の沸点の
温度まで加熱することが好ましい。また、無水の系で反
応を行うので、酢酸ナトリウムも無水のものを用いるほ
うが好適である。
Specific examples of the phthalic anhydrides include 3-nitrophthalic anhydride, 4-nitrophthalic anhydride and the like, and specific examples of the compound of the formula B include acetic anhydride, propionic anhydride,
Butyric anhydride, valeric anhydride, caproic anhydride, etc. are mentioned. As the reaction temperature, it is preferable to heat from room temperature to the temperature of the boiling point of the solvent used. Further, since the reaction is carried out in an anhydrous system, it is preferable to use anhydrous sodium acetate.

反応終了後は、フラツシユカラムクロマトグラフイー、
再結晶等の一般的な精製手法により、式Iの化合物を得
ることができる。カラムクロマトグラフイーの担体とし
ては、シリカゲル等が挙げられ、溶出溶媒としては、酢
酸エチル、n−ヘキサン、クロロホルム、ベンゼン等の
有機溶媒を単独で、あるいはそれら2種以上の混合溶媒
を用いることができる。また、再結晶の際の溶媒として
は、上記と同様の溶媒を用いることができる。
After the reaction, flash column chromatography,
The compound of formula I can be obtained by a general purification technique such as recrystallization. Examples of carriers for column chromatography include silica gel and the like, and as elution solvents, organic solvents such as ethyl acetate, n-hexane, chloroform, and benzene may be used alone, or a mixed solvent of two or more thereof may be used. it can. Further, as the solvent for recrystallization, the same solvent as described above can be used.

また、上記のようにして得られた式Iの化合物に、さら
に必要に応じ、適宜脱メチル化、脱メトキシメチル化、
還元等の操作を施してもかまわない。脱メチル化、脱メ
トキシメチル化、還元等は、上述したと同様の条件下で
達成される。
In addition, the compound of formula I obtained as described above may be further optionally demethylated, demethoxymethylated,
Operations such as reduction may be performed. Demethylation, demethoxymethylation, reduction and the like are achieved under the same conditions as described above.

次に実施例を挙げて本発明をさらに具体的に説明する。Next, the present invention will be described more specifically with reference to examples.

実施例1 ジイソプロピルアミン7.2mlを無水テトラヒドロラン90m
lに溶解させた後、−10℃に冷却し、撹拌下1.6M n−ブ
チルリチウム35.4mlを加え、30分間撹拌した。さらにこ
の溶液を−70℃に冷却し、撹拌下具体例1で得た4,5−
ジメトキシフタリド10.0gの無水テトラヒドロラン溶液
(200ml)を加えて30分間撹拌した後、−40℃に温度を
上げて塩化亜鉛8.42gの無水テトラヒドロラン溶液(100
ml)を加え、1時間撹拌した。次いで−40℃でn−ブチ
ルアルデヒド6.8mlの無水テトラヒドロラン溶液(30m
l)を加え、30分間撹拌した後、室温で終夜撹拌した。
この反応混合物を氷5%塩酸水溶液にあけ、ジエチルエ
ーテルで抽出(300ml×2)、飽和食塩水で洗浄、硫酸
マグネシウムで乾燥、溶媒を減圧除去して茶色油状物を
得た。これを、フラツシユカラムクロマトグラフイー
(シリカゲル230-400メツシユ,150g;径6.5cm,長さ10cm;
溶出液,酢酸エチル:n−ヘキサン=1:1,0.2kg/cm2)に
付し、150mlずつ分取して8〜14番目のフラクシヨンを
合併し、黄色固体の4,5−ジメトキシ−3-(1−ヒドロ
キシブチル)−フタリド13.24gを得た(収率97%)。
Example 1 7.2 ml of diisopropylamine was added to 90 ml of anhydrous tetrahydrolane.
After dissolving in 1 l, the mixture was cooled to -10 ° C, 1.6M n-butyllithium (35.4 ml) was added with stirring, and the mixture was stirred for 30 minutes. Further, this solution was cooled to -70 ° C. and stirred under stirring to obtain 4,5-
A solution of 10.0 g of dimethoxyphthalide in anhydrous tetrahydrolane (200 ml) was added and stirred for 30 minutes, then the temperature was raised to -40 ° C and a solution of 8.42 g of anhydrous tetrahydrolane in zinc chloride (100
ml) was added and stirred for 1 hour. Then, at -40 ° C, a solution of 6.8 ml of n-butyraldehyde in anhydrous tetrahydrolane (30 m
l) was added and the mixture was stirred for 30 minutes and then at room temperature overnight.
The reaction mixture was poured into iced 5% aqueous hydrochloric acid solution, extracted with diethyl ether (300 ml × 2), washed with saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a brown oil. Flash column chromatography (silica gel 230-400 mesh, 150 g; diameter 6.5 cm, length 10 cm;
The eluate, ethyl acetate: n-hexane = 1: 1,0.2 kg / cm 2 ) was collected in 150 ml aliquots and the 8th to 14th fractions were combined to give a yellow solid 4,5-dimethoxy-3. 13.24 g of-(1-hydroxybutyl) -phthalide was obtained (yield 97%).

3488,3004,2952,2932, 2860,2844,1746,1614, 1502,1456,1444,1402, 1358,1284,1226,1108, 1078,1022,974,958,878, 838,744,644 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.88,0.96(3H,t,J=6.8Hz), 1.20-1.70(4H,m), 1.92,2.79(1H,d,J=6.8,10.0Hz,D2O添加で消失), 3.95,3.96,3.98,3.98(6H,s), 5.50,5.53(1H,d,J=2.2,4.9Hz), 7.09,7.10(1H,d,J=8.3Hz), 7.64,7.65(1H,d,J=8.3Hz) マススペクトル: M/Z(%) 266(9,M+),248(3), 219(4),194(100), 179(37),166(24), 151(20),136(12), 122(14),107(16), 77(26) 次に、この4,5−ジメトキシ−3-(1−ヒドロキシブチ
ル)−フタリド12.42gをアルゴン置換した後、無水ベン
ゼン30mlを加えて溶解し、無水ピリジン7.6mlおよびメ
タンスルホニルクロライド7.2mlを室温で加えて10分間
撹拌し、さらに1時間加熱還流した。この反応混合物を
室温にもどした後、氷水にあけジエチルエーテルで抽出
(300ml×2)、水および飽和食塩水で洗浄、硫酸マグ
ネシウムで乾燥、溶媒を減圧除去して茶色油状物を得
た。これをフラツシユカラムクロマトグラフイー(シリ
カゲル,230-400メツシユ,80g,径4.5cm,長さ10cm;溶出
液,クロロホルム:塩化メチレン=1:1,0.2kg/cm2)に
付し、100mlずつ分取して3〜10番目のフラクシヨンを
合併し、無色油状物の4,5−ジメトキシ−3-(1−メタ
ンスルホニルオキシブチル)−フタリド16.03gを得た
(収率99%)。
3488,3004,2952,2932, 2860,2844,1746,1614, 1502,1456,1444,1402, 1358,1284,1226,1108, 1078,1022,974,958,878, 838,744,644 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ). : 0.88,0.96 (3H, t, J = 6.8Hz), 1.20-1.70 (4H, m), 1.92,2.79 (1H, d, J = 6.8,10.0Hz, disappears with addition of D 2 O), 3.95,3.96 , 3.98,3.98 (6H, s), 5.50,5.53 (1H, d, J = 2.2,4.9Hz), 7.09,7.10 (1H, d, J = 8.3Hz), 7.64,7.65 (1H, d, J = 8.3Hz) Mass spectrum: M / Z (%) 266 (9, M + ), 248 (3), 219 (4), 194 (100), 179 (37), 166 (24), 151 (20), 136 (12), 122 (14), 107 (16), 77 (26) Next, 12.42 g of this 4,5-dimethoxy-3- (1-hydroxybutyl) -phthalide was replaced with argon, and then 30 ml of anhydrous benzene was added. Was added and dissolved, and 7.6 ml of anhydrous pyridine and 7.2 ml of methanesulfonyl chloride were added at room temperature, the mixture was stirred for 10 minutes, and further heated under reflux for 1 hour. The reaction mixture was returned to room temperature, poured into ice water and extracted with diethyl ether (300 ml × 2), washed with water and saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a brown oil. Apply this to flash column chromatography (silica gel, 230-400 mesh, 80 g, diameter 4.5 cm, length 10 cm; eluent, chloroform: methylene chloride = 1: 1,0.2 kg / cm 2 ) in 100 ml increments. Fractionation was performed and the 3rd to 10th fractions were combined to obtain 16.03 g of 4,5-dimethoxy-3- (1-methanesulfonyloxybutyl) -phthalide as a colorless oily substance (yield 99%).

2960,2876,2840,1770, 1726,1614,1500,1462, 1352,1282,1226,1176, 1088,1076,1010,938,922, 898,800,738,526 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.84,1.03(3H,t,J=7.3Hz), 1.20-2.10(4H,m), 2.55,3.13(3H,s), 3.97,3.98,3.99,4.05(6H,s), 5.26,5.41[1H,ddd,(J=1.0,1.5,8.0Hz), (J=2.0,3.0,10.0Hz)], 5.55,5.92(1H,d,J=1.5Hz,J=2.0Hz), 7.11,7.12(1H,d,J=8.3Hz), 7.60,7.64(1H,d,J=8.3Hz) マススペクトル: M/Z(%) 344(4,M+), 248(7),219(10), 206(4),193(100), 179(3),163(5), 150(6),135(4), 122(9),79(14), 55(16) さらに、この4,5−ジメトキシ−3-(1−メタンスルホ
ニルオキシブチル)−フタリド16.03gをアルゴン置換し
た後、無水ベンゼン150mlを加えて溶解し、次いで1,8−
ジアザビシクロ[5,4,0]ウンデカ−7−エン9.75mlを
加え室温で10分間撹拌し、1時間加熱還流した。この反
応混合物を室温にもどし、氷2%塩酸水溶液100mlにあ
け、エーテルで抽出(300ml×2)、水および飽和食塩
水で洗浄、硫酸マグネシウムで乾燥、溶媒を減圧除去
し、黄色固体を得た。これをn−ヘキサンから再結晶
し、白色針状晶の(Z)‐4,5−ジメトキシ−3−ブチ
リデン−フタリド8.4gを得た。次いで母液を減圧留去し
た後、n−ヘキサンから再結晶して白色羽毛状晶の
(E)‐4,5−ジメトキシ−3−ブチリデン−フタリド1
65mgを得た。また、さらに母液をフラツシユカラムクロ
マトグラフイー(シリカゲル,230-400メツシユ,200g;径
4.5cm,長さ25cm;溶出液,塩化メチレン;0.2kg/cm2)に
付すことにより、最終的に(Z)‐4,5−ジメトキシ−
3−ブチリデン−フタリド8.58g(収率74%)、(E)
‐4,5−ジメトキシ−3−ブチリデン−フタリド461mg
(収率4.0%)を得た。
2960,2876,2840,1770, 1726,1614,1500,1462, 1352,1282,1226,1176, 1088,1076,1010,938,922, 898,800,738,526 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.84,1.03 (3H , t, J = 7.3Hz), 1.20-2.10 (4H, m), 2.55,3.13 (3H, s), 3.97,3.98,3.99,4.05 (6H, s), 5.26,5.41 [1H, ddd, (J = 1.0,1.5,8.0Hz), (J = 2.0,3.0,10.0Hz)], 5.55,5.92 (1H, d, J = 1.5Hz, J = 2.0Hz), 7.11,7.12 (1H, d, J = 8.3Hz), 7.60,7.64 (1H, d, J = 8.3Hz) Mass spectrum: M / Z (%) 344 (4, M + ), 248 (7), 219 (10), 206 (4), 193 (100), 179 (3), 163 (5), 150 (6), 135 (4), 122 (9), 79 (14), 55 (16) Furthermore, this 4,5-dimethoxy-3- ( After replacing 16.03 g of 1-methanesulfonyloxybutyl) -phthalide with argon, 150 ml of anhydrous benzene was added and dissolved, and then 1,8-
Diazabicyclo [5,4,0] undec-7-ene (9.75 ml) was added and the mixture was stirred at room temperature for 10 minutes and heated under reflux for 1 hour. The reaction mixture was returned to room temperature, poured into 100 ml of a 2% aqueous solution of hydrochloric acid in ice, extracted with ether (300 ml × 2), washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure to obtain a yellow solid. . This was recrystallized from n-hexane to obtain 8.4 g of white needle crystals of (Z) -4,5-dimethoxy-3-butylidene-phthalide. Then, the mother liquor was distilled off under reduced pressure and then recrystallized from n-hexane to give (E) -4,5-dimethoxy-3-butylidene-phthalide 1 as white feathery crystals.
Obtained 65 mg. In addition, the mother liquor was further subjected to flash column chromatography (silica gel, 230-400 mesh, 200 g;
4.5 cm, length 25 cm; eluate, methylene chloride; 0.2 kg / cm 2 ) to finally obtain (Z) -4,5-dimethoxy-
3-Butylidene-phthalide 8.58 g (74% yield), (E)
-4,5-dimethoxy-3-butylidene-phthalide 461mg
(Yield 4.0%) was obtained.

(Z)‐4,5−ジメトキシ−3−ブチリデン−フタリド 2948,2912,2872,2832, 1774,1680,1614,1498, 1458,1428,1342,1278, 1258,1194,1074,1054, 1020,992,934,888,816, 786,732,654,608 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.00(3H,t,J=7.3Hz), 1.56(2H,tq,J=7.3,7.3Hz), 2.45(2H,dt,J=7.9,7.3Hz), 3.95(3H,s),3.97(3H,s), 5.98(1H,t,J=7.9Hz), 7.04(1H,d,J=8.3Hz), 7.62(1H,d,J=8.3Hz) マススペクトル: M/Z(%) 248(24,M+), 219(100),206(18) 191(19),176(8), 163(8),148(6), 135(11),133(6), 118(6),105(9), 91(6),77(11) (E)‐4,5−ジメトキシ−3−ブチリデン−フタリド 3096,2976,2948,2868, 2840,1784,1766,1668, 1612,1588,1496,1466, 1434,1374,1332,1280, 1266,1220,1192,1102, 1074,1018,926,888,872, 828,792,732,652,580 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.00(3H,t,J=7.3Hz), 1.56(2H,tq,J=7.3,7.3Hz), 2.73(2H,dt,J=8.4,7.3Hz), 5.91(1H,t,J=8.4Hz), 7.12(1H,d,J=8.3Hz), 7.67(1H,d,J=8.3Hz) マススペクトル: M/Z(%) 248(29,M+), 219(100),206(18) 191(12),176(4), 163(4),148(3), 135(4),133(2), 131(2),105(3), 77(3) 実施例2 実施例1で得た(Z)‐4,5−ジメトキシ−3−ブチリ
デン−フタリド7.5gをアルゴン置換し、無水塩化メチレ
ン75mlを加えて溶解させた後、氷冷下0.8M三臭化ホウ素
の塩化メチレン溶液151mlを加え、30分間撹拌し、さら
に室温で3時間撹拌した。この反応混合物を氷水にあ
け、塩化メチレンで抽出し、次いで酢酸エチルで抽出
(300ml×2)、抽出液を合併して飽和食塩水で洗浄、
硫酸マグネシウムで乾燥、溶媒を減圧除去して黄色固体
を得た。これをフラツシユカラムクロマトグラフイー
(シリカゲル,230-400メツシユ,35g;径4.5cm,長さ5cm;
溶出液,アセトン:酢酸エチル=1:10,0.2kg/cm2)に付
し、50mlずつ分取して12〜23番目のフラクシヨンを合併
し、4,5−ジヒドロキシ−3−ブチリデンフタリド5.38g
を得た(収率81%)。
(Z) -4,5-dimethoxy-3-butylidene-phthalide 2948,2912,2872,2832, 1774,1680,1614,1498, 1458,1428,1342,1278, 1258,1194,1074,1054, 1020,992,934,888,816, 786,732,654,608 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 1.00 (3H, t, J = 7.3Hz), 1.56 (2H, tq, J = 7.3,7.3Hz), 2.45 (2H, dt, J = 7.9,7.3Hz), 3.95 (3H, s), 3.97 (3H, s), 5.98 (1H, t, J = 7.9Hz), 7.04 (1H, d, J = 8.3Hz), 7.62 (1H, d, J = 8.3Hz) Mass spectrum: M / Z (%) 248 (24 , M + ), 219 (100), 206 (18) 191 (19), 176 (8), 163 (8), 148 (6), 135 (11), 133 (6), 118 (6), 105 (9), 91 (6), 77 (11) (E) -4,5-dimethoxy-3-butylidene-phthalide 3096,2976,2948,2868, 2840,1784,1766,1668, 1612,1588,1496,1466, 1434,1374,1332,1280, 1266,1220,1192,1102, 1074,1018,926,888,872,828,792,732,652,580 Proton Nuclear Magnetic Resonance spectrum (δppm in CDCl 3 ): 1.00 (3H, t, J = 7.3Hz), 1.56 (2H, tq, J = 7.3,7.3Hz), 2.73 (2H, dt, J = 8.4,7.3Hz), 5.91 (1H, t, J = 8.4Hz), 7.12 (1H, d, J = 8.3Hz), 7.67 (1H, d, J = 8.3Hz) Mass spectrum: M / Z (%) 248 (29, M + ) , 219 (100), 206 (18) 191 (12), 176 (4), 163 (4), 148 (3), 135 (4), 133 (2), 131 (2), 105 (3), 77 (3) Example 2 7.5 g of (Z) -4,5-dimethoxy-3-butylidene-phthalide obtained in Example 1 was replaced with argon, and 75 ml of anhydrous methylene chloride was added and dissolved, followed by cooling with ice. 151 ml of a 0.8 M solution of boron tribromide in methylene chloride was added, and the mixture was stirred for 30 minutes and further stirred at room temperature for 3 hours. The reaction mixture was poured into ice water, extracted with methylene chloride, and then extracted with ethyl acetate (300 ml × 2). The extracts were combined and washed with saturated saline,
After drying over magnesium sulfate, the solvent was removed under reduced pressure to obtain a yellow solid. Flash column chromatography (silica gel, 230-400 mesh, 35 g; diameter 4.5 cm, length 5 cm;
Eluate, acetone: ethyl acetate = 1: 10,0.2 kg / cm 2 ) and collect 50 ml each, and combine the 12th to 23rd fractions to obtain 4,5-dihydroxy-3-butylidenephthalide 5.38. g
Was obtained (yield 81%).

3388,3170,2960,2932, 2872,1724,1678,1626, 1614,1530,1512,1456, 1394,1332,1302,1256, 1192,1156,1098,1040, 926,780,726 プロトン核磁気共鳴スペクトル(δppm in CD3OD): 1.00(3H,t,J=7.3Hz), 1.56(2H,tq,J=7.3,7.3Hz), 2.41(2H,dt,J=7.8,7.3Hz), 5.95(IH,t,J=7.8Hz), 6.95(1H,d,J=8.1Hz), 7.23(1H,d,J=8.1Hz) マススペクトル: M/Z(%) 220(34,M+), 191(100),178(60) 163(27),150(5), 145(6),135(8), 117(4),108(6), 89(5),77(4), 55(9) 実施例3 ジイソプロピルアミン5.5mlを無水テトラヒドロラン70m
lに溶解させた後、−10℃に冷却し、撹拌下1.6Mn−ブチ
ルリチウム27.0mlを加え、30分間撹拌した。さらにこの
溶液を−10℃で撹拌下、具体例2で得た4,6−ジメトキ
シ−5−メトキシメトキシフタリド10.0gの無水テトラ
ヒドロラン溶液(120ml)を加えて10分間撹拌した後、
0℃に温度を上げて1時間撹拌し、塩化亜鉛6.7gの無水
テトラヒドロラン溶液(100ml)を加え、30分間撹拌し
た。次いで−40℃に冷却し、n−ブチルアルデヒド5.2m
lの無水テトラヒドロラン溶液(20ml)を加え、30分間
撹拌した後、室温で終夜撹拌した。この反応混合物を氷
2%塩酸水溶液にあけ、ジエチルエーテルで抽出(400m
l×2)、水および飽和食塩水で洗浄、硫酸マグネシウ
ムで乾燥、溶媒を減圧除去して茶色油状物を得た。これ
を、フラツシユカラムクロマトグラフイー(シリカゲル
230-400メツシユ,300g:径6.5cm,長さ20cm;溶出液,酢酸
エチル:n−ヘキサン=2:3,0.2kg/cm2)に付し、80mlず
つ分取して18〜34番目のフラクシヨンを合併し、無色油
状物の4,6−ジメトキシ−5−メトキシメトキシ−3-
(1−ヒドロキシブチル)−フタリド4.98gを得た(収
率39%)。
3388,3170,2960,2932, 2872,1724,1678,1626, 1614,1530,1512,1456, 1394,1332,1302,1256, 1192,1156,1098,1040, 926,780,726 Proton nuclear magnetic resonance spectrum (δppm in CD 3 OD): 1.00 (3H, t, J = 7.3Hz), 1.56 (2H, tq, J = 7.3,7.3Hz), 2.41 (2H, dt, J = 7.8,7.3Hz), 5.95 (IH, t, J = 7.8Hz), 6.95 (1H, d, J = 8.1Hz), 7.23 (1H, d, J = 8.1Hz) Mass spectrum: M / Z (%) 220 (34, M + ), 191 (100) , 178 (60) 163 (27), 150 (5), 145 (6), 135 (8), 117 (4), 108 (6), 89 (5), 77 (4), 55 (9) Example 3 5.5 ml of diisopropylamine was added to 70 m of anhydrous tetrahydrolane.
After dissolving in 1 l, the mixture was cooled to -10 ° C, 27.0 ml of 1.6Mn-butyllithium was added with stirring, and the mixture was stirred for 30 minutes. Further, while stirring this solution at -10 ° C, an anhydrous tetrahydrolane solution (120 ml) of 10.0 g of 4,6-dimethoxy-5-methoxymethoxyphthalide obtained in Example 2 was added and stirred for 10 minutes,
The temperature was raised to 0 ° C. and the mixture was stirred for 1 hour, an anhydrous tetrahydrolane solution (100 ml) of 6.7 g of zinc chloride was added, and the mixture was stirred for 30 minutes. Then cooled to -40 ℃, n- butyraldehyde 5.2m
l anhydrous tetrahydrolane solution (20 ml) was added, and the mixture was stirred for 30 minutes and then at room temperature overnight. The reaction mixture was poured into ice 2% aqueous hydrochloric acid and extracted with diethyl ether (400 m
1 × 2), washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a brown oily substance. Flash column chromatography (silica gel)
230-400 mesh, 300 g: 6.5 cm in diameter, 20 cm in length; eluate, ethyl acetate: n-hexane = 2: 3, 0.2 kg / cm 2 ) A colorless oily substance, 4,6-dimethoxy-5-methoxymethoxy-3-, was combined with Fraction.
4.98 g of (1-hydroxybutyl) -phthalide was obtained (yield 39%).

3476,1956,1764,1616, 1480,1426,1344,1160, 1112,1086,1020,942, 854,766 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.88,0.97(3H,t,J=6.8Hz), 1.20-1.65(4H,m), 1.84,2.77(1H,d,J=9.3Hz,J=7.0Hz,D2O添加で消
失), 3.60(3H,s), 3.91,3.92,3.98,3.99(6H,s), 3.80-4.05(1H,m), 5.20,5.23,5.29,5.32(2H,d,J=6.0Hz), 5.46,5.49(1H,d,J=1.7Hz,J=4.9Hz), 7.17,7.18(1H,s) マススペクトル: M/Z(%) 326(1,M+), 308(1),279(4), 264(9),254(25), 235(2),224(4), 222(4),209(30), 192(4),167(9), 149(18),113(3), 45(100) 次に、この4,6−ジメトキシ−5−メトキシメトキシ−3
-(1−ヒドロキシブチル)−フタリド2.33gをアルゴン
置換した後、無水ベンゼン5mlを加えて溶解し、無水ピ
リジン1.1mlおよびメタンスルホニルクロリド1.1mlを室
温で加えて10分間撹拌し、さらに15分間加熱還流した。
この反応混合物を室温にもどした後、氷水にあけてジエ
チルエーテルで抽出(100ml×2)、水および飽和食塩
水で洗浄、硫酸マグネシウムで乾燥、溶媒を減圧除去し
て黄色油状物を得た。これをフラツシユカラムクロマト
グラフイー(シリカゲル,230-400メツシユ,80g,径4.5c
m,長さ10cm;溶出液,酢酸エチル:n−ヘキサン=2:3,0.2
kg/cm2)に付し、50mlずつ分取して8〜11番目のフラク
シヨンを合併し、白色アモルフアスの4,6−ジメトキシ
−5−メトキシメトキシ−3-(1−メタンスルホニルオ
キシブチル)−フタリド1.91gを得た(収率66%)。
3476,1956,1764,1616, 1480,1426,1344,1160, 1112,1086,1020,942, 854,766 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.88,0.97 (3H, t, J = 6.8Hz) , 1.20-1.65 (4H, m), 1.84,2.77 (1H, d, J = 9.3Hz, J = 7.0Hz, disappeared by adding D 2 O), 3.60 (3H, s), 3.91,3.92,3.98,3.99 (6H, s), 3.80-4.05 (1H, m), 5.20,5.23,5.29,5.32 (2H, d, J = 6.0Hz), 5.46,5.49 (1H, d, J = 1.7Hz, J = 4.9Hz ), 7.17,7.18 (1H, s) Mass spectrum: M / Z (%) 326 (1, M + ), 308 (1), 279 (4), 264 (9), 254 (25), 235 (2) ), 224 (4), 222 (4), 209 (30), 192 (4), 167 (9), 149 (18), 113 (3), 45 (100) Next, this 4,6-dimethoxy -5-methoxymethoxy-3
After 2.33 g of-(1-hydroxybutyl) -phthalide was replaced with argon, 5 ml of anhydrous benzene was added and dissolved, and 1.1 ml of anhydrous pyridine and 1.1 ml of methanesulfonyl chloride were added at room temperature and stirred for 10 minutes, and further heated for 15 minutes. Refluxed.
The reaction mixture was returned to room temperature, poured into ice water and extracted with diethyl ether (100 ml × 2), washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure to obtain a yellow oily substance. Flash column chromatography (silica gel, 230-400 mesh, 80 g, diameter 4.5 c
m, length 10 cm; eluate, ethyl acetate: n-hexane = 2: 3, 0.2
kg / cm 2 ), 50 ml aliquots were collected and the 8th to 11th fractions were combined, and white amorphous 4,6-dimethoxy-5-methoxymethoxy-3- (1-methanesulfonyloxybutyl)- 1.91 g of phthalide was obtained (yield 66%).

3024,2952,2870,2840, 1770,1620,1480,1430, 1354,1250,1176,1162, 1116,1106,1080,1028, 966,942,918,896,852, 804,764,558,526 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.85,1.03(3H,t,J=7.3Hz), 0.95-1.80,1.90-2.10(4H,m) 2.54,3.14(3H,s), 3.59,3.60(3H,s), 3.92,3.93,4.01,4.07(6H,s), 5.17,5.20,5.21,5.24(2H,s), 5.25,5.35(1H,ddd,J=1.5,3.0,10.0Hz,J=2.2,3.0,10.
0Hz), 5.53,5.89(1H,d,J=1.5Hz,J=2.2Hz), 7.16,7.17(1H,s) マススペクトル: M/Z(%) 404(5,M+), 372(2),309(2), 308(2),279(2), 264(33),253(4), 235(10),223(4), 209(6),45(100) さらに、この4,6−ジメトキシ−5−メトキシメトキシ
−3-(1−メタンスルホニルオキシブチル)−フタリド
1.66gをアルゴン置換した後、無水ベンゼン13mlを加え
て溶解し、次いで1,8−ジアザビシクロ[5,4,0]ウンデ
カ−7−エン0.92mlを加え室温で10分間撹拌し、1時間
加熱還流した。この反応混合物を室温にもどし、氷2%
塩酸水溶液50mlにあけ、ジエチルエーテルで抽出(100m
l×2)、水および飽和食塩水で洗浄、硫酸マグネシウ
ムで乾燥、溶媒を減圧除去し、黄色油状物を得た。これ
をフラツシユカラムクロマトグラフイー(シリカゲル,2
30-400メツシユ,200g;径4.5cm,長さ25cm;溶出液,塩化
メチレン:クロロホルム=1:1;0.2kg/cm2)に付し、30m
lずつ分取して8〜29番目のフラクシヨンを合併し、無
色油状物の(Z)‐4,6−ジメトキシ−5−メトキシメ
トキシ−3−ブチリデンフタリド802mgを得た(収率63
%)。また、31〜42番目のフラクシヨンを合併して、無
色油状物の(E)‐4,6−ジメトキシ−5−メトキシメ
トキシ−3−ブチリデンフタリド182mgを得た(収率14
%)。
3024,2952,2870,2840, 1770,1620,1480,1430, 1354,1250,1176,1162, 1116,1106,1080,1028, 966,942,918,896,852, 804,764,558,526 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.85,1.03 (3H, t, J = 7.3Hz), 0.95-1.80,1.90-2.10 (4H, m) 2.54,3.14 (3H, s), 3.59,3.60 (3H, s), 3.92,3.93,4.01,4.07 (6H , s), 5.17,5.20,5.21,5.24 (2H, s), 5.25,5.35 (1H, ddd, J = 1.5,3.0,10.0Hz, J = 2.2,3.0,10.
0Hz), 5.53,5.89 (1H, d, J = 1.5Hz, J = 2.2Hz), 7.16,7.17 (1H, s) Mass spectrum: M / Z (%) 404 (5, M + ), 372 (2 ), 309 (2), 308 (2), 279 (2), 264 (33), 253 (4), 235 (10), 223 (4), 209 (6), 45 (100) , 6-Dimethoxy-5-methoxymethoxy-3- (1-methanesulfonyloxybutyl) -phthalide
After replacing 1.66 g with argon, 13 ml of anhydrous benzene was added to dissolve it, then 0.92 ml of 1,8-diazabicyclo [5,4,0] undec-7-ene was added, and the mixture was stirred at room temperature for 10 minutes and heated under reflux for 1 hour. did. The reaction mixture is allowed to come to room temperature and ice 2%
Pour into 50 ml of aqueous hydrochloric acid and extract with diethyl ether (100 m
lx2), washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a yellow oil. Flash column chromatography (silica gel, 2
30-400 mesh, 200 g; diameter 4.5 cm, length 25 cm; eluent, methylene chloride: chloroform = 1: 1; 0.2 kg / cm 2 ), 30 m
Fractions 8 to 29 were combined by fractionation to give 802 mg of colorless oily substance (Z) -4,6-dimethoxy-5-methoxymethoxy-3-butylidenephthalide (yield 63
%). Further, the 31st to 42nd fractions were combined to obtain 182 mg of colorless oily substance (E) -4,6-dimethoxy-5-methoxymethoxy-3-butylidenephthalide (yield 14
%).

(Z)‐4,6−ジメトキシ−5−メトキシメトキシ−3
−ブチリデン−フタリド 2956,1870,2840,1776, 1681,1609,1481,1429, 1398,1337,1267,1207, 1161,1130,1100,1044, 1022,991,960,936,766 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.99(3H,t,J=7.3Hz), 1.55(2H,tq,J=7.3,7.3Hz), 2.44(2H,dt,J=7.9,7.3Hz), 3.62(3H,s),3.92(3H,s), 3.98(3H,s),5.22(2H,s), 5.84(1H,t,J=7.9Hz), 7.15(1H,s) マススペクトル: M/Z(%) 308(7,M+), 279(5),265(3), 263(4),249(3), 246(2),235(2), 233(3),221(1), 217(1),207(1), 205(1),93(1), 45(100) (E)‐4,6−ジメトキシ−5−メトキシメトキシ−3
−ブチリデンフタリド 2956,1770,1664,1610, 1480,1430,1370,1336, 1238,1204,1160,1112, 1072,1040,968,936, 848,766 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.00(3H,t,J=7.3Hz), 1.56(2H,tq,J=7.3,7.3Hz), 2.70(2H,dt,J=8.4,7.3Hz), 3.63(3H,s),3.93(3H,s), 3.94(3H,s),5.22(2H,s), 5.83(1H,t,J=8.4Hz), 7.20(1H,s) マススペクトル: M/Z(%) 308(7,M+), 279(5),265(3), 263(4),249(3), 246(2),235(2), 233(3),221(1), 217(1),207(1), 93(1),45(100) 実施例4 実施例3で得た(Z)‐4,6−ジメトキシ−5−メトキ
シメトキシ−3−ブチリデンフタリド1.23gにジオキサ
ン10mlを加えて溶解させた後、リン酸2mlを加え室温で1
0分間撹拌し、さらに10分間加熱還流した。この反応液
を室温にもどし、水1を加えて結晶を析出させ、濾取
して白色微針状晶の(Z)‐4,6−ジメトキシ−5−ヒ
ドロキシ−3−ブチリデンフタリド873mgを得た(収率8
3%) 3384,2988,2948,2864, 2832,1744,1680,1614, 1596,1502,1480,1458, 1428,1372,1336,1280, 1228,1204,1180,1152, 1098,1052,1018,960, 924,868,780,754,706, 528 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.98(3H,t,J=7.3Hz), 1.55(2H,tq,J=7.3,7.3Hz), 2.44(2H,dt,J=7.9,7.3Hz), 3.98(3H,s),4.03(3H,s), 5.85(1H,t,J=7.9Hz), 6.12(1H,s,D2O添加で消失), 7.26(1H,s) マススペクトル: M/Z(%) 264(30,M+), 235(100),222(9), 207(14),192(2), 179(3),164(2), 149(2),137(3), 55(4) 実施例5 実施例3で得た(E)‐4,6−ジメトキシ−5−メトキ
シメトキシ−3−ブチリデンフタリド145mgにジオキサ
ン1mlを加えて溶解させた後、リン酸0.25mlを加え室温
で10分間撹拌し、さらに10分間加熱還流した。この反応
液を室温にもどし、水100mlを加えて結晶を析出させ、
濾取して白色微針状晶の(E)‐4,6−ジメトキシ−5
−ヒドロキシ−3−ブチリデンフタリド91mgを得た(収
率73%)。
(Z) -4,6-dimethoxy-5-methoxymethoxy-3
-Butylidene-phthalide 2956,1870,2840,1776, 1681,1609,1481,1429, 1398,1337,1267,1207, 1161,1130,1100,1044, 1022,991,960,936,766 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.99 (3H , t, J = 7.3Hz), 1.55 (2H, tq, J = 7.3,7.3Hz), 2.44 (2H, dt, J = 7.9,7.3Hz), 3.62 (3H, s), 3.92 (3H, s) , 3.98 (3H, s), 5.22 (2H, s), 5.84 (1H, t, J = 7.9Hz), 7.15 (1H, s) Mass spectrum: M / Z (%) 308 (7, M + ), 279 (5), 265 (3), 263 (4), 249 (3), 246 (2), 235 (2), 233 (3), 221 (1), 217 (1), 207 (1), 205 (1), 93 (1), 45 (100) (E) -4,6-dimethoxy-5-methoxymethoxy-3
-Butylidenephthalide 2956,1770,1664,1610, 1480,1430,1370,1336, 1238,1204,1160,1112, 1072,1040,968,936, 848,766 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 1.00 (3H, t, J = 7.3Hz), 1.56 (2H, tq, J = 7.3,7.3Hz), 2.70 (2H, dt, J = 8.4,7.3Hz), 3.63 (3H, s), 3.93 (3H, s), 3.94 (3H , s), 5.22 (2H, s), 5.83 (1H, t, J = 8.4Hz), 7.20 (1H, s) Mass spectrum: M / Z (%) 308 (7, M + ), 279 (5) , 265 (3), 263 (4), 249 (3), 246 (2), 235 (2), 233 (3), 221 (1), 217 (1), 207 (1), 93 (1) , 45 (100) Example 4 To 1.23 g of (Z) -4,6-dimethoxy-5-methoxymethoxy-3-butylidenephthalide obtained in Example 3 was dissolved 10 ml of dioxane, and then 2 ml of phosphoric acid. Add at room temperature 1
The mixture was stirred for 0 minutes and heated under reflux for 10 minutes. The reaction solution was returned to room temperature, water 1 was added to precipitate crystals, and the crystals were collected by filtration to obtain 873 mg of (Z) -4,6-dimethoxy-5-hydroxy-3-butylidenephthalide as white fine needle crystals. (Yield 8
3%) 3384,2988,2948,2864, 2832,1744,1680,1614, 1596,1502,1480,1458, 1428,1372,1336,1280, 1228,1204,1180,1152, 1098,1052,1018,960, 924,868,780,754,706, 528 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 0.98 (3H, t, J = 7.3Hz), 1.55 (2H, tq, J = 7.3,7.3Hz), 2.44 (2H, dt, J = 7.9,7.3) Hz), 3.98 (3H, s), 4.03 (3H, s), 5.85 (1H, t, J = 7.9Hz), 6.12 (1H, s, disappears by adding D 2 O), 7.26 (1H, s) mass Spectrum: M / Z (%) 264 (30, M + ), 235 (100), 222 (9), 207 (14), 192 (2), 179 (3), 164 (2), 149 (2) , 137 (3), 55 (4) Example 5 1 ml of dioxane was added to 145 mg of (E) -4,6-dimethoxy-5-methoxymethoxy-3-butylidenephthalide obtained in Example 3 and dissolved Phosphoric acid (0.25 ml) was added, the mixture was stirred at room temperature for 10 minutes, and heated under reflux for 10 minutes. The reaction solution is returned to room temperature and 100 ml of water is added to precipitate crystals,
(E) -4,6-dimethoxy-5 in the form of fine white needle crystals was obtained by filtration.
91 mg of -hydroxy-3-butylidenephthalide was obtained (yield 73%).

3448,2952,2868,2844, 1782,1666,1620,1502, 1478,1436,1376,1332, 1266,1190,1154,1108, 1044,1026,928,866, 848,782,750,556 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.00(3H,t,J=7.3Hz), 1.55(2H,tq,J=7.3,7.3Hz), 2.71(2H,dt,J=8.4,7.3Hz), 4.00(3H,s),4.02(3H,s), 5.83(IH,t,J=8.4Hz), 6.14(1H,s,D2O添加で消失), 7.17(1H,s) マススペクトル: M/Z(%) 264(29,M+), 235(100),222(9), 207(14),192(2), 179(4),164(2), 149(3),137(3), 55(4) 実施例6 3-メトキシベンジルアルコール3.0gを窒素置換した後、
無水n-ヘキサン75mlおよびテトラメチルエチレンジアミ
ン6.9mlを加えて溶解させた。この溶液に1.6M n-ブチル
リチウム28.5mlを加え、室温で10分間撹拌した後、油浴
上で5時間加熱還流した。得られた赤褐色の懸濁液を−
78℃に冷却した後、プロピオンアルデヒド2.52gの無水n
-ヘキサン溶液(15ml)を加え、−78℃で1時間撹拌し
た後、室温で終夜撹拌した。この反応混合物に含水ジエ
チルエーテル50mlを加えて反応を終了させた後、冷却
下、希塩酸を加えて酸性とし、ジエチルエーテルで抽出
(150ml×2)、水および飽和食塩水で洗浄、硫酸マグ
ネシウムで乾燥、溶媒を減圧除去し、黄色油状物を得
た。この油状物をフラツシユカラムクロマトグラフイー
(シリカゲル,230-400メツシユ,300g,径6.5cm,長さ20c
m;溶出液,酢酸エチル:クロロホルム=1:1)に付し、5
0mlずつ分取して、12〜14番目のフラクシヨンを合併
し、3-メトキシ‐2-(1-ヒドロキシプロピル)‐ベンジ
ルアルコール1.93gを得た(収率45%)。
3448,2952,2868,2844, 1782,1666,1620,1502, 1478,1436,1376,1332, 1266,1190,1154,1108, 1044,1026,928,866, 848,782,750,556 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ). : 1.00 (3H, t, J = 7.3Hz), 1.55 (2H, tq, J = 7.3,7.3Hz), 2.71 (2H, dt, J = 8.4,7.3Hz), 4.00 (3H, s), 4.02 ( 3H, s), 5.83 (IH, t, J = 8.4Hz), 6.14 (1H, s, disappears by adding D 2 O), 7.17 (1H, s) Mass spectrum: M / Z (%) 264 (29, M + ), 235 (100), 222 (9), 207 (14), 192 (2), 179 (4), 164 (2), 149 (3), 137 (3), 55 (4) Example 6 After replacing 3.0 g of 3-methoxybenzyl alcohol with nitrogen,
75 ml of anhydrous n-hexane and 6.9 ml of tetramethylethylenediamine were added and dissolved. To this solution was added 1.6M n-butyllithium (28.5 ml), the mixture was stirred at room temperature for 10 minutes, and then heated under reflux on an oil bath for 5 hours. The obtained reddish brown suspension was-
After cooling to 78 ° C, propionaldehyde 2.52g anhydrous n
-Hexane solution (15 ml) was added, and the mixture was stirred at -78 ° C for 1 hr and then at room temperature overnight. After adding 50 ml of water-containing diethyl ether to the reaction mixture to terminate the reaction, under cooling, dilute hydrochloric acid was added to acidify, extraction with diethyl ether (150 ml x 2), washing with water and saturated saline, and drying with magnesium sulfate. The solvent was removed under reduced pressure to give a yellow oil. This oily matter was subjected to flash column chromatography (silica gel, 230-400 mesh, 300 g, diameter 6.5 cm, length 20 c).
m; eluate, ethyl acetate: chloroform = 1: 1), 5
Fractions from the 12th to 14th fractions were combined to obtain 1.93 g of 3-methoxy-2- (1-hydroxypropyl) -benzyl alcohol (yield 45%).

3384,2964,2932,2872, 2836,1584,1464,1254, 1076,1040,1012,964,744 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.93(3H,t,J=7.5Hz), 2.62-3.02(2H,m), 3.50(1H,bs,D2O添加で消失), 3.85(1H,bs,D2O添加で消失), 3.82(3H,s), 4.53(1H,d,J=12.0Hz), 4.69(1H,d,J=12.0Hz), 4.94(1H,bs), 6.84(1H,d,J=8.0Hz), 6.94(1H,d,J=8.0Hz), 7.19(1H,dd,J=8.0,8.0Hz) マススペクトル: M/Z(%) 196(1,M+), 167(28),149(100) 91(33) 次に、3-メトキシ‐2-(1-ヒドロキシプロピル)‐ベン
ジルアルコール100mgを無水ピリジン1mlに溶解させた
後、過マンガン酸テトラブチルアンモニウム515mgの無
水ピリジン溶液(4ml)を撹拌下、室温で滴下し、さら
に室温で2時間撹拌した。この反応混合物を氷冷下希塩
酸中にあけ、酸性として、ジエチルエーテルで抽出(50
ml×2)、エーテル層を5%水酸化ナトリウム溶液で抽
出し、氷冷下、希塩酸で徐々に酸性とし、ベンゼンで抽
出(50ml×3)、飽和食塩水で洗浄、硫酸マグネシウム
で乾燥、溶媒を減圧除去して、白色針状晶の3-メトキシ
‐2-プロピオニル‐安息香酸75mgを得た(収率70%)。
3384,2964,2932,2872, 2836,1584,1464,1254, 1076,1040,1012,964,744 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 0.93 (3H, t, J = 7.5Hz), 2.62-3.02 (2H, m), 3.50 (disappeared by adding 1H, bs, D 2 O), 3.85 (disappear by adding 1H, bs, D 2 O), 3.82 (3H, s), 4.53 (1H, d, J = 12.0 Hz), 4.69 (1H, d, J = 12.0Hz), 4.94 (1H, bs), 6.84 (1H, d, J = 8.0Hz), 6.94 (1H, d, J = 8.0Hz), 7.19 (1H, dd, J = 8.0,8.0Hz) Mass spectrum: M / Z (%) 196 (1, M + ), 167 (28), 149 (100) 91 (33) Next, 3-methoxy-2- (1 -Hydroxypropyl) -benzyl alcohol (100 mg) was dissolved in anhydrous pyridine (1 ml), and a solution of tetrabutylammonium permanganate (515 mg) in anhydrous pyridine (4 ml) was added dropwise with stirring at room temperature, followed by stirring at room temperature for 2 hours. The reaction mixture was poured into dilute hydrochloric acid under ice cooling, acidified, and extracted with diethyl ether (50
ml × 2), the ether layer was extracted with 5% sodium hydroxide solution, gradually acidified with dilute hydrochloric acid under ice cooling, extracted with benzene (50 ml × 3), washed with saturated saline solution, dried with magnesium sulfate, and used as a solvent. Was removed under reduced pressure to obtain 75 mg of 3-methoxy-2-propionyl-benzoic acid as white needles (yield 70%).

3348,2976,2940,2844, 1738,1614,1494,1304, 1282,1136,1056,928, 868,754 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.86(3H,t,J=7.0Hz), 1.70-2.60(1H,br,D2O添加で消失) 2.36(2H,q,J=7.0Hz), 3.94(3H,s), 7.15(1H,d,J=8.0Hz), 7.44(1H,d,J=8.0Hz), 7.52(1H,dd,J=8.0,8.0Hz) マススペクトル: M/Z(%) 208(2,M+), 179(100) 3-メトキシ‐2-プロピオニル‐安息香酸54mgを無水ベン
ゼン0.3mlに溶解させた後、室温で塩化チオニル0.06ml
を加え、30分間撹拌し、さらに油浴上で30分間加熱し
た。この反応混合物を減圧除去して過剰の塩化チオニル
を除き、結晶性の固体を得た。これをフラツシユカラム
クロマトグラフイー(シリカゲル,230-400メツシユ,50
g;径3.5cm,長さ10cm;溶出液,クロロホルム)に付し、
(Z)‐4-メトキシ‐3-エチリデンフタリド37mgを得た
(収率75%)。
3348,2976,2940,2844, 1738,1614,1494,1304, 1282,1136,1056,928, 868,754 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.86 (3H, t, J = 7.0Hz), 1.70 -2.60 (Disappeared by adding 1H, br, D 2 O) 2.36 (2H, q, J = 7.0Hz), 3.94 (3H, s), 7.15 (1H, d, J = 8.0Hz), 7.44 (1H, d , J = 8.0Hz), 7.52 (1H, dd, J = 8.0,8.0Hz) Mass spectrum: M / Z (%) 208 (2, M + ), 179 (100) 3-methoxy-2-propionyl-benzoic acid Dissolve 54 mg of acid in 0.3 ml of anhydrous benzene, then add 0.06 ml of thionyl chloride at room temperature.
Was added, stirred for 30 minutes, and heated on an oil bath for 30 minutes. The reaction mixture was removed under reduced pressure to remove excess thionyl chloride to obtain a crystalline solid. Flash column chromatography (silica gel, 230-400 mesh, 50
g; diameter 3.5 cm, length 10 cm; eluate, chloroform)
37 mg of (Z) -4-methoxy-3-ethylidenephthalide was obtained (yield 75%).

3012,2980,2944,2840, 1764,1684,1600,1494, 1434,1304,1274,1042, 996,756 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 2.01(3H,d,J=7.3Hz), 3.98(3H,s), 5.99(1H,q,J=7.3Hz), 7.12(1H,dd,J=1.5,7.5Hz), 7.41(1H,dd,J=7.5,7.5Hz), 7.47(1H,dd,J=1.5,7.5Hz) マススペクトル: M/Z(%) 190(100,M+), 175(9),171(10), 161(22),147(13), 144(14),134(25), 133(25),131(13), 105(19),104(21), 76(25) 実施例7 3-メトキシベンジルアルコール3.0gを窒素置換した後、
無水n-ヘキサン75mlおよびテトラメチルエチレンジアミ
ン6.9mlを加えて溶解させた。この溶液に1.6M n-ブチル
リチウム28.5mlを加え、室温で10分間撹拌した後、油浴
上で5時間加熱還流した。得られた赤褐色の懸濁液を−
78℃に冷却した後、n-ブチルアルデヒド3.1gの無水n-ヘ
キサン溶液(15ml)を加え、−78℃で1時間撹拌した
後、室温で終夜撹拌した。この反応混合物に含水ジエチ
ルエーテル50mlを加えて反応を終了させた後、冷却下、
希塩酸を加えて酸性とし、ジエチルエーテルで抽出(15
0ml×2)、水および飽和食塩水で洗浄、硫酸マグネシ
ウムで乾燥、溶媒を減圧除去し、黄色油状物を得た。こ
の油状物をフラツシユカラムクロマトグラフイー(シリ
カゲル,230-400メツシユ,300g,径6.5cm,長さ20cm;溶出
液,酢酸エチル:クロロホルム=1:2)に付し、50mlず
つ分取して、13〜18番目のフラクシヨンを合併し、3-メ
トキシ‐2-(1-ヒドロキシブチル)‐ベンジルアルコー
ル2.13gを得た(収率47%)。
3012,2980,2944,2840, 1764,1684,1600,1494, 1434,1304,1274,1042, 996,756 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 2.01 (3H, d, J = 7.3Hz), 3.98 (3H, s), 5.99 (1H, q, J = 7.3Hz), 7.12 (1H, dd, J = 1.5,7.5Hz), 7.41 (1H, dd, J = 7.5,7.5Hz), 7.47 (1H, dd, J = 1.5,7.5Hz) Mass spectrum: M / Z (%) 190 (100, M + ), 175 (9), 171 (10), 161 (22), 147 (13), 144 (14) , 134 (25), 133 (25), 131 (13), 105 (19), 104 (21), 76 (25) Example 7 After substituting 3.0 g of 3-methoxybenzyl alcohol with nitrogen,
75 ml of anhydrous n-hexane and 6.9 ml of tetramethylethylenediamine were added and dissolved. To this solution was added 1.6M n-butyllithium (28.5 ml), the mixture was stirred at room temperature for 10 minutes, and then heated under reflux on an oil bath for 5 hours. The obtained reddish brown suspension was-
After cooling to 78 ° C., a solution of 3.1 g of n-butyraldehyde in anhydrous n-hexane (15 ml) was added, and the mixture was stirred at −78 ° C. for 1 hour and then at room temperature overnight. After 50 ml of water-containing diethyl ether was added to the reaction mixture to terminate the reaction, under cooling,
Add dilute hydrochloric acid to acidify and extract with diethyl ether (15
It was washed with 0 ml × 2), water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure to obtain a yellow oil. This oily substance was subjected to flash column chromatography (silica gel, 230-400 mesh, 300 g, diameter 6.5 cm, length 20 cm; eluent, ethyl acetate: chloroform = 1: 2), collecting 50 ml each. , And the 13th to 18th fractions were combined to obtain 2.13 g of 3-methoxy-2- (1-hydroxybutyl) -benzyl alcohol (yield 47%).

3384,2956,2868,1584, 1468,1256,1078,1060, 1026,786,744 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.91(3H,t,J=3.0Hz), 1.04-2.04(4H,m), 3.50(1H,bs,D2O添加で消失), 3.83(3H,s), 3.84(1H,bs,D2O添加で消失), 4.53(1H,d,J=12.0Hz), 4.70(1H,d,J=12.0Hz), 5.04(1H,bs), 6.85(1H,d,J=8.0Hz), 6.95(1H,d,J=8.0Hz), 7.19(1H,dd,J=8.0,8.0Hz) マススペクトル: M/Z(%) 210(1,M+), 167(29),149(100) 91(26) 次に、3-メトキシ‐2-(1-ヒドロキシブチル)‐ベンジ
ルアルコール150mgを無水ピリジン1mlに溶解させた後、
過マンガン酸テトラブチルアンモニウム695mgの無水ピ
リジン溶液(4ml)を撹拌下、室温で滴下し、さらに室
温で2時間撹拌した。この反応混合物を氷冷下希塩酸中
にあけ、酸性として、ジエチルエーテルで抽出(50ml×
2)、エーテル層を5%水酸化ナトリウム溶液30mlで抽
出し、氷冷下、希塩酸で徐々に酸性とし、ベンゼンで抽
出(50ml×3)、飽和食塩水で洗浄、硫酸マグネシウム
で乾燥、溶媒を減圧除去して、無色油状物の3-メトキシ
‐2-ブチリル‐安息香酸115mgを得た(収率73%)。
3384,2956,2868,1584, 1468,1256,1078,1060, 1026,786,744 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 0.91 (3H, t, J = 3.0Hz), 1.04-2.04 (4H, m ), 3.50 (disappeared by adding 1H, bs, D 2 O), 3.83 (3H, s), 3.84 (disappear by adding 1H, bs, D 2 O), 4.53 (1H, d, J = 12.0Hz), 4.70 (1H, d, J = 12.0Hz), 5.04 (1H, bs), 6.85 (1H, d, J = 8.0Hz), 6.95 (1H, d, J = 8.0Hz), 7.19 (1H, dd, J = 8.0,8.0Hz) Mass spectrum: M / Z (%) 210 (1, M + ), 167 (29), 149 (100) 91 (26) Next, 3-methoxy-2- (1-hydroxybutyl) -After dissolving 150 mg of benzyl alcohol in 1 ml of anhydrous pyridine,
An anhydrous pyridine solution (4 ml) of tetrabutylammonium permanganate (695 mg) was added dropwise with stirring at room temperature, and the mixture was further stirred at room temperature for 2 hours. The reaction mixture was poured into dilute hydrochloric acid under ice cooling, acidified, and extracted with diethyl ether (50 ml x
2) The ether layer was extracted with 30 ml of 5% sodium hydroxide solution, gradually acidified with dilute hydrochloric acid under ice cooling, extracted with benzene (50 ml x 3), washed with saturated saline solution, dried with magnesium sulfate, and the solvent was added. Removal under reduced pressure gave 115 mg of 3-methoxy-2-butyryl-benzoic acid as a colorless oil (yield 73%).

3348,2952,2872,2844, 1744,1616,1492,1276, 1138,1056,932,858,756 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.91(3H,t,J=7.0Hz), 1.15-1.45(2H,m), 2.31(2H,t,J=7.0Hz), 1.95-2.80(1H,br,D2O添加で消失), 3.94(3H,s), 7.14(1H,d,J=8.0Hz), 7.44(1H,d,J=8.0Hz), 7.52(1H,dd,J=8.0,8.0Hz) マススペクトル: M/Z(%) 222(2,M+), 179(100) 3-メトキシ‐2-ブチリル‐安息香酸1.21gを無水ベンゼ
ン5mlに溶解させた後、室温で塩化チオニル1.2mlを加
え、30分間撹拌し、さらに油浴上で30分間加熱した。こ
の反応混合物を減圧除去して過剰の塩化チオニルを除
き、結晶性の固体を得た。これをフラツシユカラムクロ
マトグラフイー(シリカゲル,230-400メツシユ,80g;径
4.5cm,長さ10cm;溶出液,クロロホルム)に付し、
(Z)‐4-メトキシ‐3-プロピリデンフタリド792mgを
得た(収率71%)。
3348,2952,2872,2844, 1744,1616,1492,1276, 1138,1056,932,858,756 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.91 (3H, t, J = 7.0Hz), 1.15-1.45 (2H , m), 2.31 (2H, t, J = 7.0Hz), 1.95-2.80 (1H, br, D 2 O disappears when added), 3.94 (3H, s), 7.14 (1H, d, J = 8.0Hz) , 7.44 (1H, d, J = 8.0Hz), 7.52 (1H, dd, J = 8.0,8.0Hz) Mass spectrum: M / Z (%) 222 (2, M + ), 179 (100) 3-methoxy After 1.21 g of 2-butyryl-benzoic acid was dissolved in 5 ml of anhydrous benzene, 1.2 ml of thionyl chloride was added at room temperature, stirred for 30 minutes, and further heated on an oil bath for 30 minutes. The reaction mixture was removed under reduced pressure to remove excess thionyl chloride to obtain a crystalline solid. Flash column chromatography (silica gel, 230-400 mesh, 80 g; diameter
4.5cm, length 10cm; eluate, chloroform)
792 mg of (Z) -4-methoxy-3-propylidenephthalide was obtained (71% yield).

2956,2872,2840,1768, 1682,1604,1494,1432, 1294,1270,1042,986, 746 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.14(3H,t,J=7.5Hz), 2.49(2H,dq,J=8.0,7.5Hz), 3.99(3H,s), 5.96(1H,t,J=8.0Hz), 7.12(1H,dd,J=1.5,7.5Hz), 7.42(1H,dd,J=7.5,7.5Hz), 7.48(1H,dd,J=1.5,7.5Hz) マススペクトル: M/Z(%) 204(50,M+), 189(100),176(11), 161(14),134(13), 105(8),76(11) 実施例8 3-メトキシベンジルアルコール5.0gを窒素置換した後、
無水n-ヘキサン130mlおよびテトラメチルエチレンジア
ミン11.4mlを加えて溶解させた。この溶液に1.6M nブチ
ルリチウム47.3mlを加え、室温で10分間撹拌した後、油
浴上で5時間加熱還流した。得られた赤褐色の懸濁液を
−78℃に冷却した後、n-バレルアルデヒド6.2gの無水n-
ヘキサン溶液(20ml)を加え、−78℃で1時間撹拌した
後、室温で終夜撹拌した。この反応混合物に含水ジエチ
ルエーテル50mlを加えて反応を終了させた後、冷却下、
希塩酸を加えて酸性とし、ジエチルエーテルで抽出(20
0ml×2)、水および飽和食塩水で洗浄、硫酸マグネシ
ウムで乾燥、溶媒を減圧除去し、黄色油状物を得た。こ
の油状物をフラツシユカラムクロマトグラフイー(シリ
カゲル,230-400メツシユ,380g,径6.5cm,長さ25cm;溶出
液,酢酸エチル:クロロホルム=1:2)に付し、50mlず
つ分取して、15〜24番目のフラクシヨンを合併し、3-メ
トキシ‐2-(1-ヒドロキシペンチル)‐ベンジルアルコ
ール4.72gを得た(収率58%)。
2956,2872,2840,1768, 1682,1604,1494,1432, 1294,1270,1042,986, 746 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 1.14 (3H, t, J = 7.5Hz), 2.49 (2H, dq, J = 8.0,7.5Hz), 3.99 (3H, s), 5.96 (1H, t, J = 8.0Hz), 7.12 (1H, dd, J = 1.5,7.5Hz), 7.42 (1H, dd, J = 7.5,7.5Hz), 7.48 (1H, dd, J = 1.5,7.5Hz) Mass spectrum: M / Z (%) 204 (50, M + ), 189 (100), 176 (11), 161 (14), 134 (13), 105 (8), 76 (11) Example 8 After substituting 5.0 g of 3-methoxybenzyl alcohol with nitrogen,
130 ml of anhydrous n-hexane and 11.4 ml of tetramethylethylenediamine were added and dissolved. To this solution, 47.3 ml of 1.6 M n-butyllithium was added, and the mixture was stirred at room temperature for 10 minutes and then heated under reflux on an oil bath for 5 hours. The obtained reddish brown suspension was cooled to -78 ° C, and then n-valeraldehyde 6.2 g of anhydrous n-
A hexane solution (20 ml) was added, and the mixture was stirred at -78 ° C for 1 hr and then at room temperature overnight. After 50 ml of water-containing diethyl ether was added to the reaction mixture to terminate the reaction, under cooling,
Add dilute hydrochloric acid to acidify and extract with diethyl ether (20
It was washed with 0 ml × 2), water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure to obtain a yellow oil. This oily substance was subjected to flash column chromatography (silica gel, 230-400 mesh, 380 g, diameter 6.5 cm, length 25 cm; eluent, ethyl acetate: chloroform = 1: 2), collecting 50 ml each. , 15th to 24th fractions were combined to give 4.72 g of 3-methoxy-2- (1-hydroxypentyl) -benzyl alcohol (yield 58%).

3410,2952,2928,2860, 1584,1465,1254,1038, 1014,754 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.89(3H,t,J=3.0Hz), 096-2.04(6H,m), 2.96(1H,bs,D2O添加で消失), 3.64(1H,bs,D2O添加で消失), 3.85(3H,s), 4.58(1H,d,J=12.0Hz), 4.75(1H,d,J=12.0Hz), 5.05(1H,bs), 6.87(1H,d,J=8.0Hz), 6.96(1H,d,J=8.0Hz), 7.21(1H,dd,J=8.0,8.0Hz) マススペクトル: M/Z(%) 224(1,M+), 167(27),149(100), 91(19) 次に、3-メトキシ‐2-(1-ヒドロキシペンチル)‐ベン
ジルアルコール3.01gを無水ピリジン20mlに溶解させた
後、過マンガン酸テトラブチルアンモニウム12.09gの無
水ピリジン溶液(40ml)を撹拌下、室温で滴下し、さら
に室温で2時間撹拌した。この反応混合物を氷冷下、少
量の亜硫酸ナトリウムを含む希塩酸中にあけ、酸性とし
て、ジエチルエーテルで抽出(300ml×2)、エーテル
層を5%水酸化ナトリウム溶液100mlで抽出し、氷冷
下、希塩酸で徐々に酸性とし、ベンゼンで抽出(300ml
×2)、飽和食塩水で洗浄、硫酸マグネシウムで乾燥、
溶媒を減圧除去して、無色油状物の3-メトキシ‐2-バレ
リル‐安息香酸2.35gを得た(収率74%)。
3410,2952,2928,2860, 1584,1465,1254,1038, 1014,754 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 0.89 (3H, t, J = 3.0Hz), 096-2.04 (6H, m ), 2.96 (disappeared by adding 1H, bs, D 2 O), 3.64 (disappear by adding 1H, bs, D 2 O), 3.85 (3H, s), 4.58 (1H, d, J = 12.0Hz), 4.75 (1H, d, J = 12.0Hz), 5.05 (1H, bs), 6.87 (1H, d, J = 8.0Hz), 6.96 (1H, d, J = 8.0Hz), 7.21 (1H, dd, J = 8.0,8.0Hz) Mass spectrum: M / Z (%) 224 (1, M + ), 167 (27), 149 (100), 91 (19) Next, 3-methoxy-2- (1-hydroxypentyl) ) -Benzyl alcohol (3.01 g) was dissolved in anhydrous pyridine (20 ml), and a solution of tetrabutylammonium permanganate (12.09 g) in anhydrous pyridine (40 ml) was added dropwise with stirring at room temperature, and the mixture was further stirred at room temperature for 2 hours. The reaction mixture was poured into dilute hydrochloric acid containing a small amount of sodium sulfite under ice cooling, acidified and extracted with diethyl ether (300 ml × 2), the ether layer was extracted with 5% sodium hydroxide solution 100 ml, and cooled under ice cooling. Gradually acidify with dilute hydrochloric acid and extract with benzene (300 ml
X2), washed with saturated saline solution, dried with magnesium sulfate,
The solvent was removed under reduced pressure to obtain 2.35 g of 3-methoxy-2-valeryl-benzoic acid as a colorless oily substance (yield 74%).

3288,2952,2928,2868, 1726,1614,1492,1278, 1158,1056,852,756 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.85(3H,t,J=7.0Hz), 1.05-1.40(4H,m), 2.32(2H,t,J=7.0Hz), 3.93(3H,s), 3.50-3.98(1H,br,D2O添加で消失), 7.14(1H,dd,J=1.0,8.0Hz), 7.42(1H,dd,J=1.0,8.0Hz), 7.50(1H,dd,J=8.0,8.0Hz) マススペクトル: M/Z(%) 236(1,M+), 179(100) 3-メトキシ‐2-バレリル‐安息香酸2.08gを無水ベンゼ
ン10mlに溶解させた後、室温で塩化チオニル2.0mlを加
え、30分間撹拌し、さらに油浴上で30分間加熱した。こ
の反応混合物を減圧除去して過剰の塩化チオニルを除
き、結晶性の固体を得た。これをフラツシユカラムクロ
マトグラフイー(シリカゲル,230-400メツシユ,80g;径
4.5cm,長さ10cm;溶出液,クロロホルム)に対し、
(Z)‐4-メトキシ‐3-ブチリデンフタリド1.52gを得
た(収率78%)。
3288,2952,2928,2868, 1726,1614,1492,1278, 1158,1056,852,756 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.85 (3H, t, J = 7.0Hz), 1.05-1.40 (4H , m), 2.32 (2H, t, J = 7.0Hz), 3.93 (3H, s), 3.50-3.98 (disappeared by addition of 1H, br, D 2 O), 7.14 (1H, dd, J = 1.0,8.0) Hz), 7.42 (1H, dd, J = 1.0,8.0Hz), 7.50 (1H, dd, J = 8.0,8.0Hz) Mass spectrum: M / Z (%) 236 (1, M + ), 179 (100 ) 2.08 g of 3-methoxy-2-valeryl-benzoic acid was dissolved in 10 ml of anhydrous benzene, 2.0 ml of thionyl chloride was added at room temperature, the mixture was stirred for 30 minutes, and further heated on an oil bath for 30 minutes. The reaction mixture was removed under reduced pressure to remove excess thionyl chloride to obtain a crystalline solid. Flash column chromatography (silica gel, 230-400 mesh, 80 g; diameter
4.5 cm, length 10 cm; eluent, chloroform),
1.52 g of (Z) -4-methoxy-3-butylidenephthalide was obtained (yield 78%).

2952,2864,1768,1682, 1604,1494,1434,1282, 1042,746 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.99(3H,t,J=7.3Hz), 1.55(2H,tq,J=7.3,7.3Hz), 2.45(2H,dt,J=8.0,7.3Hz), 3.99(3H,s), 5.97(1H,t,J=8.0Hz), 7.13(1H,dd,J=1.5,7.5Hz), 7.42(1H,dd,J=7.5,7.5Hz), 7.48(1H,dd,J=1.5,7.5Hz), マススペクトル: M/Z(%) 218(23,M+), 189(100),176(6), 161(12),131(10), 105(10),76(15) 実施例9 3-メトキシベンジルアルコール3.0gを窒素置換した後、
無水n-ヘキサン75mlおよびテトラメチルエチレンジアミ
ン6.9mlを加えて溶解させた。この溶液に1.6M n-ブチル
リチウム28.5mlを加え、室温で10分間撹拌した後、油浴
上で5時間加熱還流した。得られた赤褐色の懸濁液を−
78℃に冷却した後、n-カプロアルデヒド4.6gの無水n-ヘ
キサン溶液(15ml)を加え、−78℃で1時間撹拌した
後、室温で終夜撹拌した。この反応混合物に含水ジエチ
ルエーテル50mlを加えて反応を終了させた後、冷却下、
希塩酸を加えて酸性とし、ジエチルエーテルで抽出(15
0ml×2)、水および飽和食塩水で洗浄、硫酸マグネシ
ウムで乾燥、溶媒を減圧除去し、黄色油状物を得た。こ
の油状物をフラツシユカラムクロマトグラフイー(シリ
カゲル,230-400メツシユ,300g,径6.5cm,長さ20cm;溶出
液,酢酸エチル:クロロホルム=1:2)に付し、50mlず
つ分取して、12〜18番目のフラクシヨンを合併し、3-メ
トキシ‐2-(1-ヒドロキシヘキシル)‐ベンジルアルコ
ール2.26gを得た(収率44%)。
2952,2864,1768,1682, 1604,1494,1434,1282, 1042,746 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 0.99 (3H, t, J = 7.3Hz), 1.55 (2H, tq, J = 7.3,7.3Hz), 2.45 (2H, dt, J = 8.0,7.3Hz), 3.99 (3H, s), 5.97 (1H, t, J = 8.0Hz), 7.13 (1H, dd, J = 1.5, 7.5Hz), 7.42 (1H, dd, J = 7.5,7.5Hz), 7.48 (1H, dd, J = 1.5,7.5Hz), mass spectrum: M / Z (%) 218 (23, M + ), 189 (100), 176 (6), 161 (12), 131 (10), 105 (10), 76 (15) Example 9 After replacing 3.0 g of 3-methoxybenzyl alcohol with nitrogen,
75 ml of anhydrous n-hexane and 6.9 ml of tetramethylethylenediamine were added and dissolved. To this solution was added 1.6M n-butyllithium (28.5 ml), the mixture was stirred at room temperature for 10 minutes, and then heated under reflux on an oil bath for 5 hours. The obtained reddish brown suspension was-
After cooling to 78 ° C, a solution of 4.6 g of n-caproaldehyde in anhydrous n-hexane (15 ml) was added, and the mixture was stirred at -78 ° C for 1 hr and then at room temperature overnight. After 50 ml of water-containing diethyl ether was added to the reaction mixture to terminate the reaction, under cooling,
Add dilute hydrochloric acid to acidify and extract with diethyl ether (15
It was washed with 0 ml × 2), water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure to obtain a yellow oil. This oily substance was subjected to flash column chromatography (silica gel, 230-400 mesh, 300 g, diameter 6.5 cm, length 20 cm; eluent, ethyl acetate: chloroform = 1: 2), collecting 50 ml each. , 12th-18th fraction were combined to obtain 2.26 g of 3-methoxy-2- (1-hydroxyhexyl) -benzyl alcohol (yield 44%).

3292,2956,2928,2852, 1582,1468,1262,1054, 1004,798,748 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.86(3H,t,J=7.0Hz), 0.96-2.00(8H,m), 3.60(1H,bs,D2O添加で消失), 3.81(3H,s), 4.04(1H,bs,D2O添加で消失), 4.51(1H,d,J=12.0Hz), 4.68(1H,d,J=12.0Hz), 5.02(1H,bs), 6.83(1H,d,J=8.0Hz), 6.93(1H,d,J=8.0Hz), 7.18(1H,dd,J=8.0,8.0Hz) マススペクトル: M/Z(%) 238(1,M+), 167(21),149(100) 91(25) 次に、3-メトキシ‐2-(1-ヒドロキシヘキシル)‐ベン
ジルアルコール329mgを無水ピリジン2mlに溶解させた
後、過マンガン酸テトラブチルアンモニウム1.35gの無
水ピリジン溶液(6ml)を撹拌下、室温で滴下し、さら
に室温で2時間撹拌した。この反応混合物を氷冷下、少
量の亜硫酸ナトリウムを含む希塩酸中にあけ、酸性とし
て、ジエチルエーテルで抽出(50ml×2)、エーテル層
を5%水酸化ナトリウム溶液50mlで抽出し、氷冷下、希
塩酸で徐々に酸性とし、ベンゼンで抽出(100ml×
2)、飽和食塩水で洗浄、硫酸マグネシウムで乾燥、溶
媒を減圧除去して、無色油状物の3-メトキシ‐2-ヘキサ
ノイル‐安息香酸275mgを得た(収率80%)。
3292,2956,2928,2852, 1582,1468,1262,1054, 1004,798,748 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 0.86 (3H, t, J = 7.0Hz), 0.96-2.00 (8H, m ), 3.60 (disappeared by adding 1H, bs, D 2 O), 3.81 (3H, s), 4.04 (disappear by adding 1H, bs, D 2 O), 4.51 (1H, d, J = 12.0Hz), 4.68 (1H, d, J = 12.0Hz), 5.02 (1H, bs), 6.83 (1H, d, J = 8.0Hz), 6.93 (1H, d, J = 8.0Hz), 7.18 (1H, dd, J = 8.0,8.0Hz) Mass spectrum: M / Z (%) 238 (1, M + ), 167 (21), 149 (100) 91 (25) Next, 3-methoxy-2- (1-hydroxyhexyl) After dissolving 329 mg of -benzyl alcohol in 2 ml of anhydrous pyridine, a solution of 1.35 g of tetrabutylammonium permanganate in anhydrous pyridine (6 ml) was added dropwise with stirring at room temperature and further stirred at room temperature for 2 hours. The reaction mixture was poured into dilute hydrochloric acid containing a small amount of sodium sulfite under ice cooling, acidified and extracted with diethyl ether (50 ml × 2), and the ether layer was extracted with 5 ml of 5% sodium hydroxide solution under ice cooling. Gradually acidify with dilute hydrochloric acid and extract with benzene (100 ml x
2), washed with saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure to obtain 275 mg of 3-methoxy-2-hexanoyl-benzoic acid as a colorless oil (yield 80%).

3328,2952,2928,2864, 1772,1614,1492,1276, 1140,1050,926,866,764 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.83(3H,t,J=7.0Hz), 1.03-1.47(6H,m), 2.10-2.50(2H,m), 3.90(3H,s), 5.05-6.20(1H,br,D2O添加で消失), 7.12(1H,d,J=8.0Hz), 7.35-7.55(2H,m) マススペクトル: M/Z(%) 250(1,M+), 179(100) 3-メトキシ‐2-ヘキサノイル‐安息香酸1.04gを無水ベ
ンゼン4mlに溶解させた後、室温で塩化チオニル0.9mlを
加え、30分間撹拌し、さらに油浴上で30分間加熱した。
この反応混合物を減圧除去して過剰の塩化チオニルを除
き、結晶性の固体を得た。これをフラツシユカラムクロ
マトグラフイー(シリカゲル,230-400メツシユ,80g;径
4.5cm,長さ10cm;溶出液,クロロホルム)に付し、50ml
ずつ分取して5〜8番目のフラクシヨンを合併し、
(Z)‐4-メトキシ‐3-ペンチリデンフタリド719mgを
得た(収率74%)。
3328,2952,2928,2864, 1772,1614,1492,1276, 1140,1050,926,866,764 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.83 (3H, t, J = 7.0Hz), 1.03-1.47 (6H , m), 2.10-2.50 (2H, m), 3.90 (3H, s), 5.05-6.20 (disappeared by adding 1H, br, D 2 O), 7.12 (1H, d, J = 8.0Hz), 7.35- 7.55 (2H, m) Mass spectrum: M / Z (%) 250 (1, M + ), 179 (100) 3-methoxy-2-hexanoyl-benzoic acid 1.04 g was dissolved in anhydrous benzene 4 ml, then at room temperature. 0.9 ml of thionyl chloride was added thereto, and the mixture was stirred for 30 minutes and further heated on an oil bath for 30 minutes.
The reaction mixture was removed under reduced pressure to remove excess thionyl chloride to obtain a crystalline solid. Flash column chromatography (silica gel, 230-400 mesh, 80 g; diameter
4.5cm, length 10cm; eluate, chloroform), 50ml
Each of the 5th and 8th fractions will be merged,
719 mg of (Z) -4-methoxy-3-pentylidenephthalide was obtained (yield 74%).

2948,2920,2848,1764, 1682,1604,1496,1434, 1294,1274,1042,988,746 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 0.94(3H,d,J=7.3Hz), 1.30-1.60(4H,m), 2.48(2H,dt,J=8.0,7.3Hz), 3.99(3H,s), 5.96(1H,t,J=8.0Hz), 7.12(1H,dd,J=1.5,7.5Hz), 7.42(1H,dd,J=7.5,7.5Hz), 7.48(1H,dd,J=1.5,7.5Hz), マススペクトル: M/Z(%) 232(21,M+), 189(100),176(26), 161(10),131(7), 105(14),76(5) 実施例10 3-メトキシベンジルアルコール1.38gを窒素置換した
後、無水n-ヘキサン20mlおよびテトラメチルエチレンジ
アミン3.2mlを加えて溶解させた。この溶液に1.6M n-ブ
チルリチウム13.2mlを加え、室温で10分間撹拌した後、
油浴上で5時間加熱還流した。得られた赤褐色の懸濁液
を−78℃に冷却した後、5-ホルミル‐吉草酸エチルエス
テル1.74gの無水n-ヘキサン溶液(5ml)を加え、−78℃
で30分間撹拌した後、室温で1時間撹拌した。この反応
混合物に含水ジエチルエーテル20mlを加えて反応を終了
させた後、冷却下、2%塩酸を加えて弱酸性とし、ジエ
チルエーテルで抽出(100ml×2)、水および飽和食塩
水で洗浄、硫酸マグネシウムで乾燥、溶媒を減圧除去
し、黄色油状物を得た。この油状物をフラツシユカラム
クロマトグラフイー(シリカゲル,230-400メツシユ,300
g,径4.5cm,長さ25cm;溶出液,酢酸エチル:クロロホル
ム=1:2)に付し、50mlずつ分取して、15〜18番目のフ
ラクシヨンを合併し、6-(2-ヒドロキシメチル‐6-メト
キシフエニル)‐6-ヒドロキシヘキサン酸エチル645mg
を得た(収率22%)。
2948,2920,2848,1764, 1682,1604,1496,1434, 1294,1274,1042,988,746 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 0.94 (3H, d, J = 7.3Hz), 1.30-1.60 (4H, m), 2.48 (2H, dt, J = 8.0,7.3Hz), 3.99 (3H, s), 5.96 (1H, t, J = 8.0Hz), 7.12 (1H, dd, J = 1.5,7.5) Hz), 7.42 (1H, dd, J = 7.5,7.5Hz), 7.48 (1H, dd, J = 1.5,7.5Hz), mass spectrum: M / Z (%) 232 (21, M + ), 189 ( 100), 176 (26), 161 (10), 131 (7), 105 (14), 76 (5) Example 10 After replacing 1.38 g of 3-methoxybenzyl alcohol with nitrogen, 20 ml of anhydrous n-hexane and tetra 3.2 ml of methylethylenediamine was added and dissolved. To this solution was added 1.6M n-butyllithium 13.2 ml, and after stirring at room temperature for 10 minutes,
The mixture was heated under reflux on an oil bath for 5 hours. The obtained reddish brown suspension was cooled to -78 ° C, and then an anhydrous n-hexane solution (5 ml) of 1.74 g of 5-formyl-valeric acid ethyl ester was added, and the mixture was -78 ° C.
After stirring for 30 minutes at room temperature, the mixture was stirred at room temperature for 1 hour. After adding 20 ml of water-containing diethyl ether to the reaction mixture to terminate the reaction, add 2% hydrochloric acid to make it weakly acidic under cooling, extract with diethyl ether (100 ml × 2), wash with water and saturated saline, and add sulfuric acid. The extract was dried over magnesium and the solvent was removed under reduced pressure to give a yellow oily substance. This oily matter was subjected to flash column chromatography (silica gel, 230-400 mesh, 300
g, diameter 4.5 cm, length 25 cm; eluate, ethyl acetate: chloroform = 1: 2), 50 ml aliquots were added, and the 15th-18th fractions were combined to form 6- (2-hydroxymethyl). Ethyl-6-methoxyphenyl) -6-hydroxyhexanoate 645mg
Was obtained (yield 22%).

3432,2940,2864,1730, 1584,1466,1374,1256, 1182,1074,1028,782,746 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.23(3H,t,J=7.0Hz), 1.30-2.05(6H,m), 2.27(2H,t,J=7.0Hz), 3.50(1H,bs,D2O添加で消失), 3.83(3H,s), 3.93(1H,bs,D2O添加で消失), 4.09(2H,q,J=7.0Hz), 4.53(1H,d,J=12.0Hz), 4.72(1H,d,J=12.0Hz), 5.03(1H,bs), 6.85(1H,d,J=8.0Hz), 6.94(1H,d,J=8.0Hz), 7.19(1H,dd,J=8.0,8.0Hz) マススペクトル: M/Z(%) 278(12,M+), 233(8),167(34), 149(100),91(16) 次に、6-(2-ヒドロキシメチル‐6-メトキシフエニル)
‐6-ヒドロキシヘキサン酸エチル600mgを無水ピリジン6
mlに溶解させた後、過マンガン酸テトラブチルアンモニ
ウム1.82gの無水ピリジン溶液(6ml)を撹拌下、室温で
滴下し、さらに室温で2時間撹拌した。この反応混合物
を氷冷下、少量の亜硫酸ナトリウムを含む希塩酸中にあ
け、酸性として、ベンゼンで抽出(100ml×2)、飽和
食塩水で洗浄、硫酸マグネシウムで乾燥、溶媒を減圧除
去して、黄色油状物の3-メトキシ‐2-(5-エトキシカル
ボニルバレリル)‐安息香酸508mgを得た(収率81
%)。
3432,2940,2864,1730, 1584,1466,1374,1256, 1182,1074,1028,782,746 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 1.23 (3H, t, J = 7.0Hz), 1.30-2.05 (6H, m), 2.27 (2H, t, J = 7.0Hz), 3.50 (disappeared by adding 1H, bs, D 2 O), 3.83 (3H, s), 3.93 (by adding 1H, bs, D 2 O) Loss), 4.09 (2H, q, J = 7.0Hz), 4.53 (1H, d, J = 12.0Hz), 4.72 (1H, d, J = 12.0Hz), 5.03 (1H, bs), 6.85 (1H, d, J = 8.0Hz), 6.94 (1H, d, J = 8.0Hz), 7.19 (1H, dd, J = 8.0,8.0Hz) Mass spectrum: M / Z (%) 278 (12, M + ), 233 (8), 167 (34), 149 (100), 91 (16) Next, 6- (2-hydroxymethyl-6-methoxyphenyl)
600 mg of ethyl 6-hydroxyhexanoate was added to anhydrous pyridine 6
After being dissolved in ml, a solution of 1.82 g of tetrabutylammonium permanganate in anhydrous pyridine (6 ml) was added dropwise with stirring at room temperature and further stirred at room temperature for 2 hours. The reaction mixture was poured into dilute hydrochloric acid containing a small amount of sodium sulfite under ice cooling, acidified, extracted with benzene (100 ml × 2), washed with saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a yellow color. 508 mg of 3-methoxy-2- (5-ethoxycarbonylvaleryl) -benzoic acid was obtained as an oil (yield 81
%).

3416,2936,1730,1658, 1596,1468,1276,1180, 1060,762,728 プロトン核磁気共鳴スペクトル(δppm in CDCl3): (1.00-1.80(1H,br,D2O添加で消失), 1.20(3H,t,J=7.0Hz), 1.30-1.80(4H,m), 2.10-2.48(4H,m), 3.92(3H,s), 4.06(2H,q,J=7.0Hz), 7.14(1H,d,J=8.0Hz), 7.24-7.68(2H,m) マススペクトル: M/Z(%) 308(1,M+), 256(38),179(100), 149(27),135(78), 101(27) 3-メトキシ‐2-(5-エトキシカルボニルバレリル)‐安
息香酸500mgを無水ベンゼン3mlに溶解させた後、室温で
塩化チオニル0.35mlを加え、30分間撹拌し、さらに油浴
上で30分間加熱した。この反応混合物を減圧除去して過
剰の塩化チオニルを除き、茶色油状物を得た。これをフ
ラツシユカラムクロマトグラフイー(シリカゲル,230-4
00メツシユ,160g;径4.5cm,長さ20cm;溶出液、酢酸エチ
ル:n-ヘキサン=1:2.5)に付し、50mlずつ分取して11〜
13番目のフラクシヨンを合併し、(Z)‐4-メトキシ‐
3-(4-エトキシカルボニルブチリデン)フタリド273mg
を得た(収率58%)。
3416,2936,1730,1658, 1596,1468,1276,1180, 1060,762,728 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): (1.00-1.80 (disappeared by addition of 1H, br, D 2 O), 1.20 ( 3H, t, J = 7.0Hz), 1.30-1.80 (4H, m), 2.10-2.48 (4H, m), 3.92 (3H, s), 4.06 (2H, q, J = 7.0Hz), 7.14 (1H , d, J = 8.0Hz), 7.24-7.68 (2H, m) Mass spectrum: M / Z (%) 308 (1, M + ), 256 (38), 179 (100), 149 (27), 135 (78), 101 (27) 3-methoxy-2- (5-ethoxycarbonylvaleryl) -benzoic acid (500 mg) was dissolved in anhydrous benzene (3 ml), thionyl chloride (0.35 ml) was added at room temperature, and the mixture was stirred for 30 minutes. The mixture was further heated on an oil bath for 30 minutes, and the reaction mixture was removed under reduced pressure to remove excess thionyl chloride to obtain a brown oily substance, which was then subjected to flash column chromatography (silica gel, 230-4).
00 mesh, 160 g; diameter 4.5 cm, length 20 cm; eluate, ethyl acetate: n-hexane = 1: 2.5)
Merged the 13th fraction, (Z) -4-methoxy-
3- (4-ethoxycarbonylbutylidene) phthalide 273mg
Was obtained (yield 58%).

2980,2944,1764,1730, 1684,1604,1496,1434, 1272,1160,1040,988,746 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.25(3H,t,J=7.3Hz), 1.88(2H,tt,J=7.3,7.3Hz), 2.39(2H,t,J=7.3Hz), 2.51(2H,dt,J=8.0,7.3Hz), 3.99(3H,s), 4.13(2H,q,J=7.3Hz), 5.93(1H,t,J=8.0Hz), 7.06-7.10(1H,m), 7.40-7.48(2H,m) マススペクトル: M/Z(%) 290(23,M+), 245(12),216(8), 202(100),189(19), 174(6),161(3), 131(3),83(14) 実施例11 実施例6で得た(Z)‐4-メトキシ‐3-エチリデンフタ
リド200mgをアルゴン置換した後、無水塩化メチレン2.5
mlを加えて溶解させ、これに氷冷撹拌下で、0.8M三臭化
ホウ素の塩化メチレン溶液(2.8ml)を加え、室温で4
時間撹拌した。この反応混合物を氷水50mlにあけ、ジエ
チルエーテルで抽出(100ml×2)、飽和食塩水で洗
浄、硫酸マグネシウムで乾燥、溶媒を減圧除去し、白色
固体を得た。これをベンゼンから再結晶して、白色粉状
晶の(Z)‐4-ヒドロキシ‐3-エチリデンフタリド153m
gを得た(収率83%)。
2980,2944,1764,1730, 1684,1604,1496,1434, 1272,1160,1040,988,746 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 1.25 (3H, t, J = 7.3Hz), 1.88 (2H , tt, J = 7.3,7.3Hz), 2.39 (2H, t, J = 7.3Hz), 2.51 (2H, dt, J = 8.0,7.3Hz), 3.99 (3H, s), 4.13 (2H, q, J = 7.3Hz), 5.93 (1H, t, J = 8.0Hz), 7.06-7.10 (1H, m), 7.40-7.48 (2H, m) Mass spectrum: M / Z (%) 290 (23, M + ), 245 (12), 216 (8), 202 (100), 189 (19), 174 (6), 161 (3), 131 (3), 83 (14) Example 11 Obtained in Example 6. After replacing 200 mg of (Z) -4-methoxy-3-ethylidenephthalide with argon, anhydrous methylene chloride 2.5
ml was added to dissolve it, and a 0.8 M solution of boron tribromide in methylene chloride (2.8 ml) was added thereto under ice-cooling stirring, and the mixture was stirred at room temperature for 4 minutes.
Stir for hours. The reaction mixture was poured into 50 ml of ice water, extracted with diethyl ether (100 ml × 2), washed with saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a white solid. This was recrystallized from benzene to give (Z) -4-hydroxy-3-ethylidenephthalide (153m) as white powder.
g was obtained (83% yield).

3252,2940,1744,1690, 1690,1610,1502,1468, 1312,1276,1088,1002, 976,958,748 プロトン核磁気共鳴スペクトル(δppm in CD3OD): 1.98(3H,d,J=7.3Hz), 6.00(1H,q,J=7.3Hz), 7.11(1H,dd,J=1.5,7.5Hz), 7.31(1H,dd,J=7.5Hz), 7.36(1H,dd,J=7.5,7.5Hz) マススペクトル: M/Z(%) 176(100,M+), 148(20),147(19), 120(63),92(24), 74(11) 実施例12 実施例7で得た(Z)‐4-メトキシ‐3-プロピリデンフ
タリド200mgをアルゴン置換した後、無水塩化メチレン
2.5mlを加えて溶解させ、これに氷冷撹拌下で、0.8M三
臭化ホウ素の塩化メチレン溶液(2.6ml)を加え、室温
で4時間撹拌した。この反応混合物を氷水50mlにあけ、
ジエチルエーテルで抽出(100ml×2)、飽和食塩水で
洗浄、硫酸マグネシウムで乾燥、溶媒を減圧除去し、白
色固体を得た。これをベンゼンから再結晶して、白色粉
状晶の(Z)‐4-ヒドロキシ‐3-プロピリデンフタリド
185mgを得た(収率99%)。
3252,2940,1744,1690, 1690,1610,1502,1468, 1312,1276,1088,1002, 976,958,748 Proton Nuclear Magnetic Resonance Spectrum (δppm in CD 3 OD): 1.98 (3H, d, J = 7.3Hz), 6.00 (1H, q, J = 7.3Hz), 7.11 (1H, dd, J = 1.5,7.5Hz), 7.31 (1H, dd, J = 7.5Hz), 7.36 (1H, dd, J = 7.5,7.5Hz) ) Mass spectrum: M / Z (%) 176 (100, M + ), 148 (20), 147 (19), 120 (63), 92 (24), 74 (11) Example 12 Obtained in Example 7 (Z) -4-Methoxy-3-propylidenephthalide (200 mg) was replaced with argon, and then anhydrous methylene chloride was added.
2.5 ml was added and dissolved, 0.8M methylene chloride solution of boron tribromide (2.6 ml) was added thereto with stirring under ice cooling, and the mixture was stirred at room temperature for 4 hours. Pour the reaction mixture into 50 ml of ice water,
Extraction with diethyl ether (100 ml × 2), washing with saturated brine, drying over magnesium sulfate, and removal of the solvent under reduced pressure gave a white solid. This was recrystallized from benzene to give (Z) -4-hydroxy-3-propylidenephthalide as white powder.
185 mg was obtained (99% yield).

3224,2964,2932,2872, 1740,1682,1610,1496, 1468,1300,1162,1102, 994,970,752 プロトン核磁気共鳴スペクトル(δppm in CD3OD): 1.14(3H,t,J=7.5Hz), 2.46(2H,dq,J=8.0,7.5Hz), 5.98(1H,t,J=8.0Hz), 7.11(1H,dd,J=1.5,7.5Hz), 7.31(1H,d,J=7.5Hz), 7.36(1H,dd,J=7.5,7.5Hz) マススペクトル: M/Z(%) 190(43,M+), 175(100),162(26), 147(35),120(61), 92(26) 実施例13 実施例9で得た(Z)‐4-メトキシ‐3-ペンチリデンフ
タリド200mgをアルゴン置換した後、無水塩化メチレン
2.5mlを加えて溶解させ、これに氷冷撹拌下で、0.8M三
臭化ホウ素の塩化メチレン溶液(2.3ml)を加え、室温
で4時間撹拌した。この反応混合物を氷水50mlにあけ、
ジエチルエーテルで抽出(100ml×2)、エーテル層を
飽和食塩水で洗浄、硫酸マグネシウムで乾燥、溶媒を減
圧除去し、白色固体を得た。これをベンゼンとn-ヘキサ
ンの混合溶媒から再結晶して、白色粉状晶の(Z)‐4-
ヒドロキシ‐3-ペンチリデンフタリド180mgを得た(収
率96%)。
3224,2964,2932,2872, 1740,1682,1610,1496, 1468,1300,1162,1102, 994,970,752 Proton nuclear magnetic resonance spectrum (δppm in CD 3 OD): 1.14 (3H, t, J = 7.5Hz), 2.46 (2H, dq, J = 8.0,7.5Hz), 5.98 (1H, t, J = 8.0Hz), 7.11 (1H, dd, J = 1.5,7.5Hz), 7.31 (1H, d, J = 7.5Hz) ), 7.36 (1H, dd, J = 7.5,7.5Hz) Mass spectrum: M / Z (%) 190 (43, M + ), 175 (100), 162 (26), 147 (35), 120 (61) ), 92 (26) Example 13 After 200 mg of (Z) -4-methoxy-3-pentylidenephthalide obtained in Example 9 was replaced with argon, anhydrous methylene chloride was used.
2.5 ml was added and dissolved, 0.8M methylene chloride solution of boron tribromide (2.3 ml) was added thereto with stirring under ice cooling, and the mixture was stirred at room temperature for 4 hours. Pour the reaction mixture into 50 ml of ice water,
Extraction with diethyl ether (100 ml × 2), the ether layer was washed with saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a white solid. This was recrystallized from a mixed solvent of benzene and n-hexane to give a white powder (Z) -4-
180 mg of hydroxy-3-pentylidenephthalide was obtained (96% yield).

3252,2952,2924,2856, 1740,1682,1610,1496, 1468,1298,1162,1098, 994,748 プロトン核磁気共鳴スペクトル(δppm in CD3OD): 0.96(3H,t,J=7.3Hz), 1.30-1.62(4H,m), 2.45(2H,dt,J=8.0,7.3Hz), 5.98(1H,t,J=8.0Hz), 7.11(1H,dd,J=1.5,7.5Hz), 7.32(1H,d,J=7.5Hz), 7.36(1H,dd,J=7.5,7.5Hz) マススペクトル: M/Z(%) 218(24,M+), 175(100),162(55) 147(34),134(18), 120(19),91(17), 実施例14 実施例10で得た(Z)‐4-メトキシ‐3-(4-エトキシカ
ルボニルブチリデン)フタリド60mgをアルゴン置換した
後、無水塩化メチレン0.9mlを加えて溶解させ、これに
氷冷撹拌下で0.8M三臭化ホウ素の塩化メチレン溶液(0.
8ml)を加え、室温で4時間撹拌した。この反応液に氷
水を加え、ジエチルエーテルで抽出(50ml×2)、飽和
食塩水で洗浄、硫酸マグネシウムで乾燥、溶媒を減圧除
去して、茶色固体を得た。これを薄層クロマトグラフイ
ー(展開溶媒,酢酸エチル:n-ヘキサン=1:2)に付し、
白色固体の(Z)‐4-ヒドロキシ‐3-(4-エトキシカル
ボニルブチリデン)フタリド32mgを得た(収率55%)。
3252,2952,2924,2856, 1740,1682,1610,1496, 1468,1298,1162,1098, 994,748 Proton Nuclear Magnetic Resonance Spectrum (δppm in CD 3 OD): 0.96 (3H, t, J = 7.3Hz), 1.30-1.62 (4H, m), 2.45 (2H, dt, J = 8.0,7.3Hz), 5.98 (1H, t, J = 8.0Hz), 7.11 (1H, dd, J = 1.5,7.5Hz), 7.32 (1H, d, J = 7.5Hz), 7.36 (1H, dd, J = 7.5,7.5Hz) Mass spectrum: M / Z (%) 218 (24, M + ), 175 (100), 162 (55) 147 (34), 134 (18), 120 (19), 91 (17), Example 14 60 mg of (Z) -4-methoxy-3- (4-ethoxycarbonylbutylidene) phthalide obtained in Example 10 After purging with argon, 0.9 ml of anhydrous methylene chloride was added and dissolved, and 0.8 M boron tribromide solution in methylene chloride (0.
8 ml) was added and the mixture was stirred at room temperature for 4 hours. Ice water was added to this reaction solution, extraction with diethyl ether (50 ml × 2), washing with saturated saline, drying with magnesium sulfate, and removal of the solvent under reduced pressure gave a brown solid. This was subjected to thin layer chromatography (developing solvent, ethyl acetate: n-hexane = 1: 2),
32 mg of (Z) -4-hydroxy-3- (4-ethoxycarbonylbutylidene) phthalide was obtained as a white solid (yield 55%).

3224,2976,2932,1744, 1729,1680,1608,1498, 1460,1304,1288,1160, 1080,970,756 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.28(3H,t,J=7.0Hz), 1.50-2.00(1H,br,D2O添加で消失), 1.89(2H,tt,J=7.3,7.3Hz), 2.44(2H,t,J=7.3Hz), 2.52(2H,dt,J=8.0,7.3Hz), 4.18(2H,q,J=7.0Hz), 5.94(1H,t,J=8.0Hz), 7.11(1H,dd,J=1.0,7.5Hz), 7.32(1H,t,J=7.5Hz), 7.44(1H,dd,J=7.5Hz) マススペクトル: M/Z(%) 276(14,M+), 231(10),202(7), 188(100),175(22) 166(12),147(9), 91(9) 実施例15 実施例10で中間体として得た3-メトキシ‐2-(5-エトキ
シカルボニルバレリル)‐安息香酸200mgをメタノール1
mlに溶解させた後、5%水酸化ナトリウム1mlを加え、
室温で30分間撹拌した。この反応液を減圧除去した後、
氷冷下希塩酸を加えて酸性とし、ジエチルエーテルで抽
出(100ml×2)、飽和食塩水で洗浄、硫酸マグネシウ
ムで乾燥、溶媒を減圧除去して黄色油状物を得た。これ
をクロロホルムとn-ヘキサンの混合溶媒から再結晶し
て、白色針状晶の6-(2-カルボキシ‐6-メトキシ‐フエ
ニル)‐6-オキソヘキサン酸163gを得た(収率89%)。
3224,2976,2932,1744, 1729,1680,1608,1498, 1460,1304,1288,1160, 1080,970,756 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 1.28 (3H, t, J = 7.0Hz) , 1.50-2.00 (Disappeared by adding 1H, br, D 2 O), 1.89 (2H, tt, J = 7.3,7.3Hz), 2.44 (2H, t, J = 7.3Hz), 2.52 (2H, dt, J) = 8.0,7.3Hz), 4.18 (2H, q, J = 7.0Hz), 5.94 (1H, t, J = 8.0Hz), 7.11 (1H, dd, J = 1.0,7.5Hz), 7.32 (1H, t) , J = 7.5Hz), 7.44 (1H, dd, J = 7.5Hz) Mass spectrum: M / Z (%) 276 (14, M + ), 231 (10), 202 (7), 188 (100), 175 (22) 166 (12), 147 (9), 91 (9) Example 15 200 mg of 3-methoxy-2- (5-ethoxycarbonylvaleryl) -benzoic acid obtained as an intermediate in Example 10 was added to methanol. 1
After dissolving in 1 ml, add 1 ml of 5% sodium hydroxide,
Stir for 30 minutes at room temperature. After removing the reaction solution under reduced pressure,
The mixture was acidified with diluted hydrochloric acid under ice cooling, extracted with diethyl ether (100 ml × 2), washed with saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a yellow oil. This was recrystallized from a mixed solvent of chloroform and n-hexane to obtain 163 g of white needle crystals of 6- (2-carboxy-6-methoxy-phenyl) -6-oxohexanoic acid (yield 89%). .

3300-2500,2936,1692, 1582,1464,1300,1260, 1204,1060,762 プロトン核磁気共鳴スペクトル(δppm in acetone-
d6): 1.20-1.70(4H,m), 2.27(2H,t,J=7.0Hz), 2.37(2H,t,J=7.0Hz), 3.95(3H,s), 7.36(2H,d,J=8.0Hz), 7.56(1H,t,J=8.0Hz) マススペクトル: M/Z(%) 280(10,M+), 262(17),202(72), 180(100),151(15) 135(17) 次に、この6-(2-カルボキシ‐6-メトキシ‐フエニル)
‐6-オキソヘキサン酸40mgを無水ベンゼン0.2mlに溶解
させた後、室温で塩化チオニル0.03mlを加えて30分間撹
拌し、さらに油浴上にて30分間加熱した。反応終了後、
反応液を減圧除去して、過剰の塩化チオニルを除き、結
晶性の固体を得た。これを薄層クロマトグラフイー(展
開溶媒;5%メタノール/塩化メチレン)に付し、白色粉
状晶の(Z)‐4-メトキシ‐3-(4-カルボキシブチリデ
ン)フタリド27mgを得た(収率73%)。
3300-2500,2936,1692, 1582,1464,1300,1260, 1204,1060,762 Proton Nuclear Magnetic Resonance Spectrum (δppm in ozone-
d 6 ): 1.20-1.70 (4H, m), 2.27 (2H, t, J = 7.0Hz), 2.37 (2H, t, J = 7.0Hz), 3.95 (3H, s), 7.36 (2H, d, J = 8.0Hz), 7.56 (1H, t, J = 8.0Hz) Mass spectrum: M / Z (%) 280 (10, M +), 262 (17), 202 (72), 180 (100), 151 ( 15) 135 (17) Next, this 6- (2-carboxy-6-methoxy-phenyl)
After dissolving 40 mg of -6-oxohexanoic acid in 0.2 ml of anhydrous benzene, 0.03 ml of thionyl chloride was added at room temperature and the mixture was stirred for 30 minutes, and further heated on an oil bath for 30 minutes. After the reaction,
The reaction solution was removed under reduced pressure to remove excess thionyl chloride to obtain a crystalline solid. This was subjected to thin layer chromatography (developing solvent; 5% methanol / methylene chloride) to obtain 27 mg of (Z) -4-methoxy-3- (4-carboxybutylidene) phthalide as white powdery crystals ( Yield 73%).

3300-2500,2948,2918, 1766,1718,1694,1604, 1496,1434,1272,1042, 988,746 プロトン核磁気共鳴スペクトル(δppm in CDCl3-CD3O
D): 1.88(2H,tt,J=7.5Hz), 2.40(2H,t,J=7.5Hz), 2.54(2H,dt,J=8.0,7.5Hz), 4.02(3H,s), 6.00(1H,t,J=8.0Hz), 7.23(1H,dd,J=1.5,7.0Hz), 7.40-7.56(2H,m) マススペクトル: M/Z(%) 262(12,M+), 244(3),216(6), 202(100),189(34) 174(8),161(9), 131(8),105(6), 103(7),76(7) 実施例16 実施例15で得た(Z)‐4-メトキシ‐3-(4-カルボキシ
ブチリデン)フタリド34mgを無水塩化メチレン0.5mlに
溶解させ、氷冷下0.8M三臭化ホウ素の塩化メチレン溶液
0.5mlを加え、室温で2時間撹拌した。この反応液に氷
水を加え、ジエチルエーテルで抽出(50ml×2)、飽和
食塩水で洗浄、硫酸マグネシウムで乾燥、溶媒を減圧除
去して、茶色固体を得た。これをオープンカラムクロマ
トグラフイー(シリカゲル:80-230メツシユ,約5g,溶出
液:10%メタノール/塩化メチレン)に付し、白色固体
の(Z)‐4-ヒドロキシ‐3-(4-カルボキシブチリデ
ン)フタリド16mgを得た(収率51%)。
3300-2500,2948,2918, 1766,1718,1694,1604, 1496,1434,1272,1042, 988,746 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 -CD 3 O
D): 1.88 (2H, tt, J = 7.5Hz), 2.40 (2H, t, J = 7.5Hz), 2.54 (2H, dt, J = 8.0,7.5Hz), 4.02 (3H, s), 6.00 ( 1H, t, J = 8.0Hz), 7.23 (1H, dd, J = 1.5,7.0Hz), 7.40-7.56 (2H, m) Mass spectrum: M / Z (%) 262 (12, M + ), 244 (3), 216 (6), 202 (100), 189 (34) 174 (8), 161 (9), 131 (8), 105 (6), 103 (7), 76 (7) Example 16 34 mg of (Z) -4-methoxy-3- (4-carboxybutylidene) phthalide obtained in Example 15 was dissolved in 0.5 ml of anhydrous methylene chloride, and 0.8 M boron tribromide solution in methylene chloride was cooled with ice.
0.5 ml was added, and the mixture was stirred at room temperature for 2 hours. Ice water was added to this reaction solution, extraction with diethyl ether (50 ml × 2), washing with saturated saline, drying with magnesium sulfate, and removal of the solvent under reduced pressure gave a brown solid. This was subjected to open column chromatography (silica gel: 80-230 mesh, about 5 g, eluent: 10% methanol / methylene chloride) to give a white solid (Z) -4-hydroxy-3- (4-carboxybutyrate). 16 mg of (ridene) phthalide was obtained (yield 51%).

2340,2928,1746,1690, 1608,1498,1462,1296, 1166,1130,1078,970,754 プロトン核磁気共鳴スペクトル(δppm in acetone-
d6): 1.85(2H,tt,J=7.3,7.3Hz), 2.41(2H,t,J=7.3Hz), 2.52(2H,dt,J=8.0,7.3Hz), 5.99(1H,t,J=8.0Hz), 7.26(1H,dd,J=7.5Hz), 7.36-7.48(2H,m) マススペクトル: M/Z(%) 248(11,M+), 230(7),202(10), 188(100),175, 160(11),149(20), 147(17),120(9), 91(13) 実施例17 実施例15で得た(Z)‐4-メトキシ‐3-(4-カルボキシ
ブチリデン)フタリド20mgを無水テトラヒドロフラン0.
5mlに溶解させ、これに氷冷下1Mのジボランのテトラヒ
ドロフラン溶液0.16mlを滴下し、そのまま氷冷下で30分
間撹拌し、さらに室温で3時間撹拌した。この反応液
に、氷水5mlを加え、ジエチルエーテルで抽出、飽和食
塩水で洗浄、硫酸マグネシウムで乾燥し、溶媒を減圧除
去して白色固体が得られた。これを薄層クロマトグラフ
イー(展開溶媒;酢酸エチル:クロロホルム)に付し、
(Z)‐4-メトキシ‐3-(5-ヒドロキシペンチリデン)
フタリド10mgを得た(収率53%)。
2340,2928,1746,1690, 1608,1498,1462,1296, 1166,1130,1078,970,754 Proton nuclear magnetic resonance spectrum (δppm in ozone-
d 6 ): 1.85 (2H, tt, J = 7.3,7.3Hz), 2.41 (2H, t, J = 7.3Hz), 2.52 (2H, dt, J = 8.0,7.3Hz), 5.99 (1H, t, J = 8.0Hz), 7.26 (1H, dd, J = 7.5Hz), 7.36-7.48 (2H, m) Mass spectrum: M / Z (%) 248 (11, M + ), 230 (7), 202 ( 10), 188 (100), 175, 160 (11), 149 (20), 147 (17), 120 (9), 91 (13) Example 17 (Z) -4-methoxy obtained in Example 15 20 mg of 3- (4-carboxybutylidene) phthalide was added to anhydrous tetrahydrofuran.
After dissolving in 5 ml, 0.16 ml of a 1 M tetrahydrofuran solution of diborane was added dropwise under ice cooling, and the mixture was stirred under ice cooling for 30 minutes, and further stirred at room temperature for 3 hours. Ice water (5 ml) was added to the reaction solution, which was extracted with diethyl ether, washed with saturated brine and dried over magnesium sulfate, and the solvent was removed under reduced pressure to give a white solid. Apply this to thin layer chromatography (developing solvent; ethyl acetate: chloroform),
(Z) -4-Methoxy-3- (5-hydroxypentylidene)
10 mg of phthalide was obtained (yield 53%).

3360,2940,2586,1768, 1682,1604,1494,1434, 1274,1042,986,746 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.40-1.80(5H,m), 2.51(2H,dt,J=8.0,7.0Hz), 3.69(2H,t,J=6.0Hz), 3.99(3H,s), 5.96(1H,t,J=8.0Hz), 7.13(1H,dd,J=7.5,1.5Hz), 7.43(1H,t,J=7.5Hz), 7.49(1H,dd,J=7.5,1.5Hz) マススペクトル: M/Z(%) 248(41,M+), 220(45),202(36), 189(100),177(91) 163(26),161(24), 149(73),129(36), 73(75) 実施例18 無水3-ニトロフタル酸25g、無水酢酸ナトリウム10.6gお
よび無水吉草酸50.7mlを室温で加え、油浴上で140〜160
℃で撹拌しながら3時間加熱した。反応終了後、反応液
を減圧留去し、この残渣に水、アンモニア水50mlを加
え、ジエチルエーテルで抽出(500ml×2)、硫酸マグ
ネシウムで乾燥、溶媒を減圧留去して、茶色油状物を得
た。この油状物をフラツシユカラムクロマトグラフイー
(シリカゲル,230-400メツシユ;径6.5cm,長さ30cm;約4
50g;溶出液,酢酸エチル:n-ヘキサン=1:2.5)に付し、
50mlずつ分取し、13〜16番目のフラクシヨンを合併し
て、再びフラツシユカラムクロマトグラフイー(シリカ
ゲル,230-400メツシユ;径6.5cm,長さ30cm;約450g;溶出
液,クロロホルム:ベンゼン=1:2)に付し、50mlずつ
分取し、12〜15番目のフラクシヨンを合併して、(Z)
‐4-ニトロ‐3-ブチリデンフタリド0.90gを得た(収率
3%)。また、29〜44番目のフラクシヨンを合併して、
(Z)‐7-ニトロ‐3-ブチリデンフタリド1.55gを得た
(収率5%)。
3360,2940,2586,1768, 1682,1604,1494,1434, 1274,1042,986,746 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 1.40-1.80 (5H, m), 2.51 (2H, dt, J = 8.0,7.0Hz), 3.69 (2H, t, J = 6.0Hz), 3.99 (3H, s), 5.96 (1H, t, J = 8.0Hz), 7.13 (1H, dd, J = 7.5,1.5Hz) , 7.43 (1H, t, J = 7.5Hz), 7.49 (1H, dd, J = 7.5,1.5Hz) Mass spectrum: M / Z (%) 248 (41, M + ), 220 (45), 202 ( 36), 189 (100), 177 (91) 163 (26), 161 (24), 149 (73), 129 (36), 73 (75) Example 18 25 g of 3-nitrophthalic anhydride, anhydrous sodium acetate 10.6 g and 50.7 ml of valeric anhydride at room temperature, add 140-160 on an oil bath.
Heated at 0 ° C. with stirring for 3 hours. After completion of the reaction, the reaction solution was distilled off under reduced pressure, water and 50 ml of aqueous ammonia were added to the residue, extracted with diethyl ether (500 ml x 2), dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to give a brown oily substance. Obtained. Flash oil column chromatography (silica gel, 230-400 mesh; diameter 6.5 cm, length 30 cm; about 4
50 g; eluate, ethyl acetate: n-hexane = 1: 2.5),
Fractions of 50 ml each are collected, and the 13th to 16th fractions are combined, and the column is again subjected to flash column chromatography (silica gel, 230-400 mesh; diameter 6.5 cm, length 30 cm; about 450 g; eluent, chloroform: benzene = 1: 2), collect 50 ml each, combine the 12th to 15th fractions, (Z)
0.90 g of 4-nitro-3-butylidenephthalide was obtained (yield 3%). Also, by merging the 29th to 44th fractions,
1.55 g of (Z) -7-nitro-3-butylidenephthalide was obtained (yield 5%).

(Z)‐4-ニトロ‐3-ブチリデンフタリド 3092,2964,2936,2860, 1786,1662,1616,1530, 1468,1340,1268,1150, 1094,1028,990,832,784, 766,742,690,602 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.01(3H,t,J=7.3Hz), 1.60(2H,t-q,J=7.3,7.3Hz), 2.54(2H,dt,J=7.8,7.3Hz), 6.60(1H,t,J=7.8Hz), 7.51(1H,t,J=7.5Hz), 8.24(1H,dd,J=7.5,1.0Hz), 8.39(1H,dd,J=7.5,1.0Hz) マススペクトル: M/Z(%) 233(M+,25), 204(35),188(64), 175(34),161(25), 147(15),146(15), 130(32),104(60), 102(64),89(45), 75(100) (Z)‐7-ニトロ‐3-ブチリデンフタリド 3084,2956,2932,2860, 1776,1686,1620,1536, 1472,1354,1238,1156, 1096,1000,826,776,732, 682 プロトン核磁気共鳴スペクトル(δppm in CDCl3): 1.00(3H,t,J=7.3Hz), 1.58(2H,tq,J=7.3,7.3Hz), 2.49(2H,dt,J=7.9,7.3Hz), 5.82(1H,t,J=7.9Hz), 7.78-7.96(3H,m) マススペクトル: M/Z(%) 233(M+,57), 204(100), 191(52), 177(55),161(54), 148(23),130(30), 104(53),103(53), 75(94) 本発明の化合物はプロスタグランジンF2α阻害作用を有
し、医薬品として有用である。このことについて実験例
を挙げて説明する。
(Z) -4-Nitro-3-butylidenephthalide 3092,2964,2936,2860, 1786,1662,1616,1530, 1468,1340,1268,1150, 1094,1028,990,832,784, 766,742,690,602 Proton nuclear magnetic resonance spectrum (δppm in CDCl 3 ): 1.01 (3H, t, J = 7.3Hz), 1.60 (2H, tq, J = 7.3,7.3Hz), 2.54 (2H, dt, J = 7.8,7.3Hz), 6.60 (1H, t, J = 7.8Hz), 7.51 (1H, t , J = 7.5Hz), 8.24 (1H, dd, J = 7.5,1.0Hz), 8.39 (1H, dd, J = 7.5,1.0Hz) Mass spectrum: M / Z (%) 233 (M + , 25) , 204 (35), 188 (64), 175 (34), 161 (25), 147 (15), 146 (15), 130 (32), 104 (60), 102 (64), 89 (45) , 75 (100) (Z) -7-nitro-3-butylidenephthalide 3084,2956,2932,2860, 1776,1686,1620,1536, 1472,1354,1238,1156, 1096,1000,826,776,732, 682 Proton Nuclear Magnetic Resonance Spectrum (δppm in CDCl 3 ): 1.00 (3H, t, J = 7.3Hz), 1.58 (2H, tq, J = 7.3,7.3Hz), 2.49 (2H, dt, J = 7.9,7.3Hz), 5.82 (1H, t, J = 7.9Hz), 7.78-7.96 (3H) , m) Mass spectrum: M / Z (%) 233 (M + , 57), 204 (100), 191 (52), 177 (55), 161 (54), 148 (23), 130 (30), 104 (53), 103 (53), 75 (94) The compound of the present invention has a prostaglandin F2α inhibitory action and is useful as a pharmaceutical. This will be described with reference to experimental examples.

実験例 ウイスター系雌性ラツトの卵巣を摘出し、その約3週間
後に子宮角を摘出した。各子宮角をマグヌス管につる
し、気泡を通じ25℃に保つたロツク−リンガー液に浸し
て、プロスタグランジンF2αの添加による収縮をペンレ
コーダーで記録した。実施例8、10、13および15で得た
化合物は最終濃度が5×10-6g/mlとなるようにエタノー
ルに溶解し、プロスタグランジンF2αを添加する3〜5
分前に添加した。その収縮の結果より実施例で得た化合
物のプロスタグランジンF2α阻害率を次式により算出し
た。
Experimental Example The ovaries of the Wistar female rat were removed, and about 3 weeks after that, the uterine horns were removed. Each uterine horn was suspended in a Magnus tube, immersed in Rock-Ringer's solution kept at 25 ° C. through air bubbles, and contraction due to addition of prostaglandin F2α was recorded with a pen recorder. The compounds obtained in Examples 8, 10, 13 and 15 were dissolved in ethanol so that the final concentration was 5 × 10 −6 g / ml, and prostaglandin F2α was added 3-5.
Added minutes before. From the result of the contraction, the prostaglandin F2α inhibition rate of the compound obtained in Example was calculated by the following formula.

A:実施例で得た化合物を含まない場合の収縮度 B:実施例で得た化合物添加の場合の収縮度 その結果を第1表に示す。 A: Shrinkage when the compound obtained in the example is not included B: Shrinkage when the compound obtained in the example is added The results are shown in Table 1.

また、実施例で得た化合物には、血液粘度低下作用、抗
ヒアルロニダーゼ作用、抗血小板凝集作用、抗ヒスタミ
ン作用、抗真菌作用のあることが認められた。
Further, it was confirmed that the compounds obtained in the examples have blood viscosity lowering action, anti-hyaluronidase action, anti-platelet aggregation action, anti-histamine action and anti-fungal action.

本発明の化合物はそのまま、あるいは慣用の製剤担体と
共に動物および人に投与することができる。投与形態と
しては、特に限定がなく、必要に応じ適宜選択して使用
され、錠剤、カプセル剤、顆粒剤等の経口剤、注射剤、
坐剤等の非経口剤が挙げられる。錠剤、カプセル剤、顆
粒剤等の経口剤は常法に従つて製造される。錠剤は本発
明の化合物をゼラチン、でん粉、乳糖、ステアリン酸マ
グネシウム、滑石、アラビアゴム等の製剤学的賦形剤と
混合し賦形することにより製造され、カプセル剤は、本
発明の化合物を不活性の製剤充填剤、もしくは希釈剤と
混合し、硬質ゼラチンカプセル、軟質ゼラチンカプセル
等に充填することにより製造される。シロツプ剤、エリ
キシル剤は、本発明の化合物をシヨ糖等の甘味剤、メチ
ルおよびプロピルパラベン類等の防腐剤、着色剤、調味
剤、芳香剤、補助剤と混合して製造される。
The compound of the present invention can be administered to animals and humans as it is or together with a conventional pharmaceutical carrier. The dosage form is not particularly limited and may be appropriately selected and used as necessary. Oral agents such as tablets, capsules and granules, injections,
Parenteral agents such as suppositories may be mentioned. Oral preparations such as tablets, capsules and granules are manufactured according to a conventional method. Tablets are produced by mixing and shaping the compound of the present invention with pharmaceutical excipients such as gelatin, starch, lactose, magnesium stearate, talc, gum arabic, etc. It is produced by mixing with an active pharmaceutical filler or diluent and filling it into a hard gelatin capsule, a soft gelatin capsule or the like. Syrups and elixirs are produced by mixing the compound of the present invention with sweeteners such as sucrose, preservatives such as methyl and propylparabens, colorants, seasonings, fragrances, and auxiliary agents.

非経口剤は常法に従つて製造され、希釈剤として一般に
注射用蒸留水、生理食塩水、デキストロース水溶液、プ
ロピレングリコール等を用いることができる。さらに必
要に応じて、殺菌剤、防腐剤、安定剤を加えてもよい。
また、この非経口剤は安定性の点から、アンプル等に充
填後冷凍し、通常の凍結乾燥技術により水分を除去し、
使用直前に凍結乾燥物から液剤を再調製することもでき
る。
The parenteral preparation is produced according to a conventional method, and distilled water for injection, physiological saline, dextrose aqueous solution, propylene glycol or the like can be generally used as a diluent. Further, if necessary, a bactericide, a preservative, and a stabilizer may be added.
In addition, from the viewpoint of stability, this parenteral preparation is frozen after filling into ampoules and the like, and water is removed by a normal freeze-drying technique.
It is also possible to reconstitute a solution from a lyophilized product just before use.

その他の非経口剤としては、外用液剤、軟膏等の塗布
剤、直腸内投与のための坐剤等が挙げられ、常法に従つ
て製造される。
Other parenteral agents include liquid preparations for external use, coating agents such as ointments, suppositories for rectal administration, and the like, and they are manufactured by a conventional method.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 J.Nat.Prod.,49(1), 184−5(1986) Plaut.Med.Phytothe v.,17(3),147−56(1983) Planta Medica,50 (1),105−6(1984) ─────────────────────────────────────────────────── ─── Continuation of the front page (56) References J. Nat. Prod. , 49 (1), 184-5 (1986) Plaut. Med. Phytothe v. , 17 (3), 147-56 (1983) Planta Medica, 50 (1), 105-6 (1984)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式I (式中、R1は水素原子、水酸基、メトキシ基またはニト
ロ基を示し、R2は水素原子、水酸基、メトキシ基または
メトキシメトキシ基を示し、R3は水素原子またはメトキ
シ基を示し、R4は水素原子またはニトロ基を示し、R5
水素、アルキル基、−C3H6COOH、−C3H6COOC2H5または
−C4H8OHを示す。 ただし、R1、R2、R3およびR4が共通して水素原子である
場合、R1が水素原子であり、R2が水酸基であり、R3およ
びR4がともに水素原子であり、R5がn−プロピル基であ
る場合、およびR1およびR2がともに水素原子であり、R3
がメトキシ基であり、R4が水素原子であり、R5がメチル
基である場合、およびR1およびR2がメトキシ基であり、
R3およびR4が水素原子であり、R5がメチル基である場
合、およびR1が水酸基であり、R2、R3およびR4がともに
水素原子であり、R5がプロピル基である場合を除く。) で表される新規なフタリド誘導体。
1. A general formula I (In the formula, R 1 represents a hydrogen atom, a hydroxyl group, a methoxy group or a nitro group, R 2 represents a hydrogen atom, a hydroxyl group, a methoxy group or a methoxymethoxy group, R 3 represents a hydrogen atom or a methoxy group, and R 4 Represents a hydrogen atom or a nitro group, R 5 represents hydrogen, an alkyl group, —C 3 H 6 COOH, —C 3 H 6 COOC 2 H 5 or —C 4 H 8 OH, provided that R 1 , R 2 , R 3 and R 4 are a hydrogen atom in common, R 1 is a hydrogen atom, R 2 is a hydroxyl group, R 3 and R 4 are both hydrogen atoms, and R 5 is an n-propyl group. And R 1 and R 2 are both hydrogen atoms, and R 3
Is a methoxy group, R 4 is a hydrogen atom, R 5 is a methyl group, and R 1 and R 2 are methoxy groups,
When R 3 and R 4 are hydrogen atoms, R 5 is a methyl group, and R 1 is a hydroxyl group, R 2 , R 3 and R 4 are both hydrogen atoms, and R 5 is a propyl group. Excluding cases. ) A novel phthalide derivative represented by:
JP22826486A 1986-09-29 1986-09-29 Phthalide derivative Expired - Lifetime JPH07108906B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22826486A JPH07108906B2 (en) 1986-09-29 1986-09-29 Phthalide derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22826486A JPH07108906B2 (en) 1986-09-29 1986-09-29 Phthalide derivative

Publications (2)

Publication Number Publication Date
JPS6383081A JPS6383081A (en) 1988-04-13
JPH07108906B2 true JPH07108906B2 (en) 1995-11-22

Family

ID=16873749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22826486A Expired - Lifetime JPH07108906B2 (en) 1986-09-29 1986-09-29 Phthalide derivative

Country Status (1)

Country Link
JP (1) JPH07108906B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4713134B2 (en) * 2004-11-26 2011-06-29 高砂香料工業株式会社 Process for producing optically active alkylphthalides
JP5581120B2 (en) * 2010-06-07 2014-08-27 花王株式会社 Voltage-gated cation channel inhibitor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
J.Nat.Prod.,49(1),184−5(1986)
PlantaMedica,50(1),105−6(1984)
Plaut.Med.Phytothev.,17(3),147−56(1983)

Also Published As

Publication number Publication date
JPS6383081A (en) 1988-04-13

Similar Documents

Publication Publication Date Title
US4752613A (en) Sulphonamidothienylcarboxylic acid compounds
JPS582935B2 (en) 5↓-Production method of aroylpyrrole derivative
JP2839805B2 (en) Lignan analog, method for producing the same, and antihyperlipidemic agent
US3780061A (en) Tricyclic ketonic compounds
US4605664A (en) Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treatment of grey matter edema
US4596821A (en) Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones
US3468939A (en) 4- and 5-aryl-1-naphthaleneacetic acid compounds
US4604403A (en) Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema
US4444981A (en) 10 Oxo-4,5-dihydro-10H-benzo 5,6 cycloheph[1,2-B]pyrryls
US4605663A (en) Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, for treatment of grey matter edema
JPH07108906B2 (en) Phthalide derivative
JP2001527073A (en) N-phenylamide derivative and N-pyridylamide derivative, process for producing the compound, and pharmaceutical composition containing the compound
US4680414A (en) Substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones
JP2873599B2 (en) Novel benzofuran derivative, uric acid excreting agent and method for producing the same
EP0142754A2 (en) 2-Substituted-benzoic acid imidazoles, process for preparing them and pharmaceutical compositions containing them
JPH07119188B2 (en) Chalcone derivative
AU643125B2 (en) Quinone derivatives
EP0011282B1 (en) Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds
JPS6013761A (en) Novel pyridyl ether derivative
JPH0798815B2 (en) Phthalide derivative
GB2209336A (en) Germinally substituted cyclic ether carboxylic acids
HU181450B (en) Process for preparing aurone derivatives
JP2549997B2 (en) New haloketal compound
JPS5824587A (en) Oxothienobenzoxepine and manufacture
JP2953653B2 (en) Method for producing piperidine derivative